Page last updated: 2024-08-21

isoxazoles and risperidone

isoxazoles has been researched along with risperidone in 433 studies

Research

Studies (433)

TimeframeStudies, this research(%)All Research%
pre-19908 (1.85)18.7374
1990's192 (44.34)18.2507
2000's112 (25.87)29.6817
2010's118 (27.25)24.3611
2020's3 (0.69)2.80

Authors

AuthorsStudies
Lindström, E; von Knorring, L4
Heykants, J; Lorreyne, W; Van Rompaey, F; Woestenborghs, R1
Awouters, FH; Janssen, PA; Meert, TF; Megens, AA; Niemegeers, CJ; Schellekens, KH1
Awouters, FH; Megens, AA; Niemegeers, CJ2
Gommeren, W; Janssen, PA; Janssen, PM; Leysen, JE; Pauwels, PJ; Wynants, J1
Bollen, J; Claus, A; De Cuyper, H; Eneman, M; Heylen, S; Malfroid, M; Peuskens, J1
Baert, AL; Bollen, J; Claus, A; De Cuyper, H; Eneman, M; Heylen, S; Malfroid, M; Peuskens, J; Van Ongeval, C; Wilms, G1
Gelders, YG; Heylen, SL1
Müller-Spahn, F1
Marder, SR1
Bowden, CR; De Coster, R; Heykants, J; Voina, SJ; Woestenborghs, R1
Borison, RL; Diamond, BI; Meibach, RC; Pathiraja, AP1
Benkert, O; Hillert, A; Maier, W; Wetzel, H1
Awouters, F; Janssen, PA; Megens, AA; Niemegeers, CJ1
Gelders, YG; Heylen, SL; Janssen, PA; Reyntjens, AJ; Vanden Bussche, G1
Bogdanov, MB; Gaĭnetdinov, RR; Kudrin, VS; Medvedev, OS; Val'dman, AV1
Gerlach, J1
Kissling, W; Möller, HJ; Pelzer, E; Riehl, T; Wernicke, T1
Awouters, F; Janssen, PA; Meert, TF; Megens, AA; Niemegeers, CJ; Schellekens, KH1
de Chaffoy de Courcelles, D; Eens, A; Gommeren, W; Janssen, PA; Leysen, JE; Stoof, JC1
de Haes, P; Janssen, PA; Meert, TF1
Burton, P; Gelders, Y; Heylen, S; Mesotten, F; Pietquin, M; Suy, E1
Gelders, YG1
de Bruyckere, K; Janssen, PF; Leysen, JE; Schotte, A1
Dugovic, C; Janssen, PA; Wauquier, A1
Kerwin, R1
Jeffries, JJ1
MacEwan, GW1
Ereshefsky, L; Lacombe, S1
Arnott, W; Chouinard, G1
Remington, GJ2
Kane, JM4
Busatto, GF; Costa, DC; Ell, PJ; Kerwin, RW; Pilowsky, LS; Verhoeff, NP2
Livingston, MG1
Ciccocioppo, R; Massi, M; Panocka, I; Pompei, P1
Fensbo, C; Høyberg, OJ; Lingjaerde, O; Remvig, J; Salvesen, I; Sloth-Nielsen, M1
Heinrich, K; Hruschka, H; Kinzler, E; Klieser, E; Lehmann, E1
Janssen, PF; Leysen, JE; Megens, AA; Schotte, A1
Czyrak, A; Frankiewicz, T; Maj, J; Rogóz, Z; Skuza, G1
Aghajanian, GK; Gellman, RL1
Kerwin, RW1
Alessandria, A; Bonifati, V; Giustini, P; Meco, G1
Marder, SR; Meibach, RC1
Awouters, FH; Janssen, PA1
Kido, H; Mori, H; Sakamoto, H; Shiba, K; Sumiyoshi, T; Suzuki, K; Urasaki, K; Yamaguchi, N; Yokogawa, K1
Davidson, JE; Mosqueda, RA1
Edwards, JG1
Dalby, JT; Dickson, R; Williams, R1
Emes, CE; Millson, RC1
Land, W; Salzman, C1
Littrell, K; Schultz, RE1
Jahnová, E1
Dwight, MM; Keck, PE; McElroy, SL; Stanton, SP; Strakowski, SM1
Mok, H; Yatham, LN1
Heykants, J; Huang, ML; Mannens, G; Meuldermans, W; Snoeck, E; Van Beijsterveldt, L; Van Peer, A; Woestenborghs, R1
McEvoy, JP1
Schooler, NR1
Owens, DG1
Janssen, PM; Leysen, JE; Megens, AA; Schotte, A1
Ford, B; Greene, P; Lynch, T1
Goodman, WK; McDougle, CJ; Price, LH1
Sussman, N1
Catalan, J; Singh, AN1
Webster, P; Wijeratne, C1
Honer, WG; Kopala, L1
Goldberg, TE; Weinberger, DR1
Cozza, SJ; Edison, DL1
Aschauer, H; Kasper, S; Stamenkovic, M1
Finlayson, R; Jones, BD; Labelle, A; Purdon, SE1
Jones, BD; Labelle, A; Lit, W; Purdon, SE1
Fitton, A; Grant, S1
Eilers, R1
Elomaa, E; Raitasuo, V; Vataja, R1
Brammer, M; Bullmore, E; David, A; Howard, R; Mellers, J; Williams, S; Woodruff, P1
Bennett, JA; Keck, PE; Wallhausser, LJ1
Bennie, EH1
Adams, M; Remington, G1
Brocco, M; Millan, MJ; Schreiber, R1
Eriksson, B; Eriksson, L; Farde, L; Halldin, C; Nyberg, S1
Janssen, PM; Leysen, JE; Luyten, WH; Megens, AA; Schotte, A1
Borison, RL; Diamond, B; Meibach, RC; Pathiraja, A1
Post, L1
Bruggeman, R; van der Linden, C; van Woerkom, TC1
Geerts, RJ; Heykants, JJ; Leysen, JE; Megens, AA; Meuldermans, WE; van Beijsterveldt, LE; Van den Eynde, HM1
Awouters, FH; Dugovic, C; Leysen, JE; Meert, TF; Megens, AA; Niemegeers, CJ; Schotte, A1
Beaudry, P; Bélanger, MC; Chouinard, G; Miller, R; Roy, JY; Turnier, L; Vainer, JL1
Perrault, G; Sanger, DJ1
Auchus, AP; Freeman, A; Green, RC1
Heykants, J; Mannens, G; Meuldermans, W; Snoeck, E1
Furukawa, H; Hasegawa, T; Kitaichi, K; Nabeshima, T; Yamada, K1
Furukawa, H; Hasegawa, T; Kitaichi, K; Nabeshima, T; Ogita, K; Yamada, K; Yoneda, Y1
Keegan, D1
Villeneuve, A1
Sigmundson, HK1
Holt, L; O'Croinin, F; Zibin, T1
Lee, MA; Meltzer, HY; Ranjan, R1
Black, DW; Gupta, S; Smith, DA1
Honer, WG; Kopala, LC1
Clarke, DE; Yaeger, SF1
Bryois, C1
Ericsson, B; Farde, L; Halldin, C; Nakashima, Y; Nyberg, S; Oxenstierna, G1
Borison, RL1
Chouinard, G1
Heinrich, K; Kinzler, E; Klieser, E; Lehmann, E; Wurthmann, C1
Tavares, AR1
DeVane, CL1
Love, RC1
Perry, PJ1
Curtis, VA; Kerwin, RW1
Breier, A1
Sternlicht, HC; Wells, SR1
Pickar, D1
Borison, RL; Chouinard, G; Möller, HJ; Müller, H; Schooler, NR1
McEvoy, JP; Price, WA; Swanson, CL1
Byerly, MJ; Evans, DL; Greer, RA1
Silva, JA; Smith, EA; Tekell, JL1
Giakas, WJ1
Zimbroff, DL1
Dalby, JT; Dickson, RA; Edwards, AL; Williams, R1
Pelonero, AL1
Allen, RL; D'Ath, PJ; Katona, CL; Walker, Z1
Price, PL1
Möller, HJ1
Lindenmayer, JP1
Azorin, JM1
Aubert, AC; Baumann, P; Bondolfi, G; Meylan, C1
Farde, L; Hall, H; Halldin, C; Nyberg, S; Sedvall, G1
Shulman, LM; Singer, C; Weiner, WJ1
He, H; Richardson, JS1
McCarthy, RH; Terkelsen, KG1
Huttunen, MO; Larmo, I; Nyholm, R; Piepponen, T; Raitasuo, V; Rantanen, H1
Allen, M; Field, K; Ganguli, R; Reddy, R; Tanner, TB1
Dave, M1
Boland, RJ; Richards, C; Singer, S1
Alderman, CP; Fraser, CD1
Davis, YB; Jeanblanc, W1
Cott, J; Lieberman, JA; Matthews, S; Shore, D1
Borison, RL; Brown, TM; Radford, JM1
Kirisci, L; Musser, WS1
Goss, JB1
Houle, S; Kapur, S; Remington, G; Wilson, AA; Zipursky, RB1
Fras, I; Major, LF1
Jerkovich, GS; Lacey, RL; Preskorn, SH1
Devane, CL; Risch, SC; Tyson, SC1
Ballard, CG; Harrison, RW; McKeith, IG1
Benvenga, MJ; Leander, JD1
Cardoni, AA1
Peuskens, J1
Jacobsen, FM1
Goodnick, PJ1
Kane, JM; McGlashan, TH1
Dahl, ML; Halldin, C; Nyberg, S1
Conway, PG; Corbett, R; Cornfeldt, M; Rush, DK; Strupczewski, JT; Szewczak, MR; Wilmot, CA1
Buttiëns, M; Dierick, G; Geutjens, J; Heylen, S; Sieben, G; Thiry, P; Vanden Borre, R; Vermote, R1
Addington, D; Arnott, W; Beauclair, L; Bloom, D; Chouinard, G; Jones, B; Labelle, A; MacEwan, GW; Remington, G1
Massi, M; Panocka, I; Pompei, P1
Koyama, T; Kusumi, I; Matsubara, R; Matsubara, S; Yamashita, I1
Remr, J1
Jahnová, E; Keleová, A; Nyulassy, S1
Conway, PC; Corbett, R; Dunn, RW; Hartman, H; Helsley, GC; Kerman, LL; Strupczewski, JT; Woods, AT1
Edouard, S; Le Moing, JP; Levron, JC1
Hayakawa, H; Kawai, K; Kikumoto, O; Motohashi, N; Okamoto, Y; Yamawaki, S; Yokota, N1
Matsubara, R1
Menkes, DB1
Aravagiri, M; Marder, SR; Midha, KK; Van Putten, T1
Assié, MB; Koek, W; Sleight, AJ1
De Coster, R; Heykants, J; Huang, ML; Jansen, AA; Jonkman, JH; Van Peer, A; Visscher, HW; Woestenborghs, R; Zylicz, Z1
Czyrak, A; Jaros, T; Maj, J; Moryl, E1
Kang, DY; Kim, CE; Min, SK; Rhee, CS1
Bigg, DC; Koek, W; Sleight, AJ1
Czobor, P; Volavka, J1
Cesková, E; Svestka, J1
Brenner, C; Brown, K; Hamburg, EL; Leffler, S; Levy, H1
Hoffman, DW; Price, MC1
Linnet, K; Olesen, OV1
Aravagiri, M; Marder, SR; Wirshing, D; Wirshing, WC1
Bruun, T; Licht, RW; Linnet, K; Olesen, OV; Thomsen, E; Viftrup, JE1
Aravagiri, M; Marder, SR; Yuwiler, A1
Baker, GB; Bourin, M; Fang, J1
Albano, D; Amchin, J; Klockowski, PM; Taylor, KP; Zarycranski, W1
Cho, MJ; Jang, IJ; Kwon, JS; Lee, DY; Lee, KU; Shin, SG; Woo, JI1
Bork, JA; de Leon, J; Rogers, T; Wedlund, PJ1
Saria, A; Schatz, DS1
Avenoso, A; Dahl, ML; Facciolà, G; Johansson, I; Scordo, MG; Spina, E1
Doorschot, CH; Loonen, AJ; Oostelbos, MC; Sitsen, JM1
Furukori, H; Kaneko, S; Nagasaki, T; Ohkubo, T; Sugawara, K; Yasui, N1
Hackett, LP; Hill, RC; Ilett, KF; McIvor, RJ; Wojnar-Horton, RE1
Cui, D; Kamel, A; Miceli, JJ; Prakash, C; Tweedie, D; Whalen, RD1
Chang, WH; Chiu, WC; Chou, JC; Lane, HY; Su, MH; Wu, ST1
Aravagiri, M; Marder, SR2
Nakamura, J; Terao, T; Ueda, N; Yoshimura, R1
Avenoso, A; Facciolà, G; Giacobello, T; Madia, AG; Perucca, E; Salemi, M; Scordo, MG; Spina, E1
Aamo, T; Güzey, C; Spigset, O1
Avenoso, A; Facciolà, G; Salemi, M; Spina, E1
Ancione, M; Avenoso, A; Facciolà, G; Madia, AG; Perucca, E; Salemi, M; Scordo, MG; Spina, E1
Ancione, M; Avenoso, A; Facciolà, G; Madia, A; Scordo, MG; Spina, E1
Nakamura, J; Ueda, N; Yoshimura, R1
Albert, MJ; Baldessarini, RJ; Centorrino, F; Kelleher, JP1
Déridet, E; Moore, N; Titier, K1
Abouelfath, A; Cardone, E; Déridet, E; Moore, N; Titier, K1
Kastango, KB; Kirshner, MA; Maxwell, RA; Mulsant, BH; Pollock, BG; Rosen, J; Sweet, RA1
Fukuda, M; Iga, T; Nakashima, Y; Ohno, Y; Sato, H; Sawada, Y; Takayanagi, R; Tsuchiya, F; Yamada, Y1
Thiam, S; Valle, BC; Warner, IM; Zhu, X1
Berecz, R; Cáceres, M; de la Garza, CS; Dorado, P; Gutiérrez, JR; LLerena, A; Norberto, MJ1
Huang, F; Janssens, L; Lasseter, KC; Lau, H; Verhaeghe, T; Zhao, Q1
de Jong, J; de Vries, R; Hooijschuur, EW; Remmerie, BM; Schothuis, AM; Sips, LL; van de Merbel, NC1
Berecz, R; de la Rubia, A; Degrell, I; Dorado, P; Gómez, J; Kellermann, M; LLerena, A1
Xiao, H; Yang, J; Zhang, S; Zhang, X1
Kalkman, HO; Loetscher, E1
De Vries, R; Iga, T; Kaneko, S; Kondo, T; Kubota, T; Mihara, K; Takarada, Y; Tateishi, T; Yasui-Furukori, N1
de Vries, R; Iga, T; Ishida, M; Kaneko, S; Kondo, T; Kubota, T; Mihara, K; Ono, S; Suzuki, A; Takarada, Y; Yasui-Furukori, N1
Ko, G; Lasseter, KC; Lechat, P; Mannaert, E; Remmerie, BM; van Schaick, EA1
Aravagiri, M; Gitlin, MJ; Marder, SR; Nuechterlein, KH1
Begg, EJ; Gardiner, SJ; Hackett, LP; Ilett, KF; Kristensen, JH; Vaddadi, KS1
Aman, M; Flarakos, J; Gerber, N; Luo, W; Svinarov, D; Vouros, P1
Chang, JW; Chen, PS; Liao, YC; Su, SF; Yang, YK; Yeh, TL1
De Vries, R; Kaneko, S; Kondo, T; Mihara, K; Nakagami, T; Suzuki, A; Takahata, T; Tateishi, T; Yasui-Furukori, N1
Calamoneri, F; D'Arrigo, C; Gagliano, A; Germanò, E; Impallomeni, C; Pustorino, G; Spina, E1
Ancione, M; D'Arrigo, C; Madia, A; Migliardi, G; Morgante, L; Spina, E; Zoccali, R1
Berecz, R; de la Rubia, A; Dorado, P; Llerena, A1
De Clerck, F; Eerdekens, M; Greenspan, A; Mannaert, E; Somers, Y1
Foltz, RL; Huang, W; Laycock, JD; Moody, DE1
Möller, HJ; Müller, N; Müller-Arends, A; Riedel, M; Schwarz, MJ; Spellmann, I; Strassnig, M; Weber, K; Zach, J1
Castberg, I; Spigset, O1
DeVane, CL; Donovan, JL; Markowitz, JS; Ruan, Y; Taylor, RM; Wang, JS1
Björner, A; Eerdekens, M; Eriksson, B; Gefvert, O; Helldin, L; Mannaert, E; Nyberg, S; Persson, P; Remmerie, B1
Aichhorn, W; Stuppaeck, C; Whitworth, AB1
Goto, M; Kaji, K; Kakihara, S; Matsumoto, C; Nakamura, J; Ohmori, O; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R1
Baselmans, P; Bosker, F; Bruggeman, R; Castelein, S; Knegtering, R; van den Bosch, RJ1
Aichhorn, W; Geretsegger, C; Kemmler, G; Marksteiner, J; Stelzig-Schoeler, R; Stuppaeck, C; Walch, T; Weiss, U; Zernig, G1
Kaneo, S; Nakagami, T; Saito, M; Tateishi, T; Yasui-Furukori, N1
Kapur, B; Koren, G; Railton, CJ1
Furukori, H; Kaneko, S; Nakagami, T; Saito, M; Yasui-Furukori, N1
Chan, YH; Chong, SA; Tan, CH; Verma, SK1
Byun, WT; Cho, HK; Jung, IG; Jung, SM; Kim, KA; Park, JY; Park, PW1
Ariën, A; Brewster, M; Mathot, F; Préat, V; van Beijsterveldt, L1
Deng, CY; Li, HD; Li, WB; Li, X; Lin, QX; Lin, SG; Peng, HY; Su, FL; Wang, CY; Wang, F; Yang, M; Yu, XY; Zhou, ZL; Zhu, RH1
Kapur, S; Labelle, A; Mamo, D; Mann, S; Mannaert, E; Reiss, J; Remington, G; Shammi, C1
Bastianetto, S; Danik, M; Mennicken, F; Quirion, R; Williams, S1
Hendset, M; Nesvåg, R; Refsum, H; Tanum, L1
Bhatt, J; Singh, S; Subbaiah, G1
Didriksen, M; Kreilgaard, M; Olsen, CK1
DeVane, CL; Donovan, JL; Markowitz, JS; Wang, JS; Zhu, HJ1
Cho, HY; Lee, YB1
DeVane, CL; Donovan, JL; Gibson, BB; Markowitz, JS; Wang, JS; Zhu, HJ1
Duan, S; Feng, G; Gao, R; He, L; Li, H; Meng, J; Qin, S; Xing, Q; Xu, M; Zhang, A1
Melkersson, KI1
Ludwig, EA; Piotrovsky, V; Vermeulen, A1
Buitelaar, JK; Hermans, MH; Hoekstra, PJ; Lahuis, BE; Minderaa, RB; Scahill, L; Troost, PW; van Engeland, H1
Nakamura, J; Shinkai, K; Ueda, N; Yoshimura, R1
Cabovska, B; Cox, SL; Vinks, AA1
Hori, H; Kakihara, S; Mitoma, M; Nakamura, J; Nakano, Y; Ohta, M; Shinkai, K; Shinkai, T; Sugita, A; Ueda, N; Umene, W; Yoshimura, R1
D'Hoore, P; Kushner, S; Mannaert, E; Remmerie, B; Thyssen, A1
Blier, P; Dremencov, E; El Mansari, M1
Diaz, FJ; Leon, Jd; Orrego, ML; Pan, RM; Susce, MT; Wedlund, PJ1
Piniella, PM; Relleke, M; van Os, S1
Canuso, CM; Kujawa, M; Mahmoud, R; Pandina, GJ; Youssef, E1
Azarzar, D; Bartélémy, C; Bonte, JP; Chaminade, P; Danel, C; Odou, P; Vaccher, C1
Azarzar, D; Barthélémy, C; Bonte, JP; Danel, C; Odou, P; Robert, H; Vaccher, C1
Ding, JJ; Jiao, Z; Shi, XJ; Yu, YQ1
Du, J; Fang, C; Feng, GY; Gu, NF; He, L; Li, XW; Qin, SY; Wang, L; Xing, QH; Yu, L; Zhang, AP1
Bartlett, MG; Terry, AV; Zhang, G1
Aman, MG; Lindsay, RL; Malone, K; Mannaert, E; Masty, J; Ramadan, Y; Remmerie, B; Vinks, AA1
Bharathi, Ch; Chary, DK; Dandala, R; Handa, VK; Kumar, MS; Naidu, A; Shankar, R1
Crocq, MA; Duval, F; Garcia Duarte, F; Guillon, MS; Mokrani, MC1
Awouters, FH; Lewi, PJ1
Kim, KA; Kim, KB; Lee, HJ; Liu, KH; Park, JY; Park, PW; Shin, JG1
Henken, S; Hiemke, C; Kirschbaum, KM; Schmitt, U1
Dopheide, JA1
Deyo, Z; Dolder, C; Nelson, M1
Nussbaum, A; Stroup, TS1
Bossie, CA; Canuso, CM; Schreiner, A; Simpson, GM; Turkoz, I; Youssef, EA1
Boom, S; De Meulder, M; de Vries, R; Hooijschuur, EW; Remmerie, BM; Sips, LL; Timmerman, PM; van de Merbel, NC1
Darby, JK; Herbert, J; Pasta, DJ; Wilson, MG1
Dahl, ML; Gunes, A; Scordo, MG; Spina, E1
Eliasson, E; Mannheimer, B; Pettersson, H; von Bahr, C1
Clement, HW; Heiser, P; Hemmeter, UM; Krieg, JC; Schmidt, AJ; Schulz, E; Vedder, H1
Lublin, HK; Maknyte, K1
Aravagiri, M; Bies, RR; Coley, K; Feng, Y; Kirshner, M; Marder, S; Miller, D; Pollock, BG; Schneider, L1
Klein, MT; Knight, JA; Smith, C; Teitler, M; Toohey, N2
Chen, CC; Chiu, CC; Huang, MC; Pan, CH; Peng, PW; Tsai, CJ1
Azaroual, N; Brunel, A; Danel, C; Lannoy, D; Odou, P; Vaccher, C; Vermeersch, G1
Friberg, LE; Karlsson, MO; Petersson, KJ; Vermeulen, AM1
Cabré, F; Cánovas, M; Cebrecos, J; Delgadillo, J; Pelagio, P; Riba, N; Torres, F1
Graff-Guerrero, A; Kapur, S; Mamo, DC; Mulsant, BH; Pollock, BG; Uchida, H1
Marchese, G; Pani, L1
Charles, B; Dean, AJ; Jones, T; McDermott, BM; Norris, R; Van Breda, K1
Kumar, R; Sachdev, PS1
Chino, B; Kosaki, K; Mizuno, M; Sakuma, K; Sato, Y; Takao, T; Takebayashi, T; Yagihashi, T1
Che, R; Du, J; Feng, G; Gu, N; He, L; Li, X; Lin, Z; Wang, L; Xing, Q; Xuan, J; Yu, L; Zhang, A1
Cho, HK; Han, C; Jung, BJ; Jung, SM; Kang, RH; Kim, KA; Kim, SH; Kim, YK; Lee, DK; Lee, MS; Park, JY1
Chen, CH; Chiu, CC; Huang, MC; Lai, YC; Pan, CH; Tsai, CJ1
Furukori, H; Kaneko, S; Kondo, T; Nakagami, T; Saito, M; Suzuki, A; Yasui-Furukori, N1
Klein, MT; Knight, J; Smith, C; Teitler, M; Toohey, N1
De Rossi, P; Girardi, P; Kotzalidis, GD; Lionetto, L; Lostia, AM; Mazzarini, L; Pacchiarotti, I; Sani, G; Sanna, L; Simmaco, M; Tatarelli, R1
Grabnar, I; Locatelli, I; Mrhar, A1
Mühe, A; Neels, H; Schneider, S; Sibille, E; Wennig, R; Yegles, M1
Casu, G; Deriu, A; Lazzari, P; Marchese, G; Pani, L; Peddio, G; Pira, M; Pisu, C; Pittau, B; Portesani, F; Spada, GP1
Berwaerts, J; Boom, S; Cleton, A; Eerdekens, M; Janssens, L; Kramer, M; Remmerie, B; Rossenu, S; Talluri, K1
Arakawa, R; Ito, H; Kodaka, F; Miyoshi, M; Okumura, M; Otsuka, T; Suhara, T; Takahashi, H; Takano, H1
Hendset, M; Hermann, M; Molden, E; Refsum, H1
Elliott, ES; Nelson, LA; Purvis, TL; Sommi, RW1
Gründer, G; Orfanos, S; Paulzen, M1
Alphs, L; Awad, AG; Canuso, CM; Damaraju, CV; Grinspan, A; Kalali, A; Merriman, U1
Cui, YM; Duan, JL; Xiang, Q; Zhao, X; Zhou, Y1
Burger, R; Fegert, J; Gerlach, M; Klampfl, K; Mehler-Wex, C; Pfuhlmann, B; Preuss, A; Rothenhöfer, S; Taurines, R; Wewetzer, Ch1
Bader, W; Gründer, G; Haen, E; Hiemke, C; Nazirizadeh, Y; Paulzen, M; Pfuhlmann, B; Schwarz, M; Vogel, F; Zernig, G1
Baldi, ML; Cerveri, G; De Gaspari, IF; Mauri, MC; Mencacci, C; Papa, P; Rolandi, ML; Volonteri, LS1
Božina, N; Jakovljević, M; Jovanović, N; Lovrić, M; Medved, V; Peleš, AM1
Fukui, N; Inoue, Y; Ono, S; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J1
Li, Y; Meng, Q; Su, Z; Sui, C; Sun, F; Teng, L; Yuan, L; Zhang, C1
Hopkins, T; Nasrallah, HA; Pixley, SK1
D'Souza, DC; Kane, JM; Keefe, RS; Patkar, AA; Tiller, JM; Yang, R; Youakim, JM1
Atallah, AN; Melnik, T; Puga, ME; Soares, BG1
Alphs, L; Gopal, S; Karcher, K; Kent, J; Kushner, S; Nuamah, I; Singh, J; Sliwa, JK1
Bourcier, E; Brovedani, S; Lancelin, F; Le Masson, V; Lemeille, Y; Paubel, P; Piketty, ML1
Gassmann-Mayer, C; Gopal, S; Hough, D; Lane, R; Pandina, G; Remmerie, B; Simpson, G1
Anyama, NG; Bies, RR; Lieberman, JA; Marder, SR; Pollock, BG; Schneider, LS; Wessels, AM1
Belotto, KC; Ferreira, AS; Gattaz, WF; Raposo, NR1
Boncompagni, G; Lateana, D; Mandrioli, R; Mercolini, L; Raggi, MA1
Boonleang, J; Mahatthanatrakul, W; Pipatrattanaseree, W; Tanthana, C1
Bossie, CA; Canuso, CM; Lindenmayer, JP; Schooler, N; Turkoz, I1
Gu, N; Li, H; Ning, X; Rui, Q; Xu, H1
Alves, I; Nuss, P; Salgado, GF; Staneva, G; Tessier, C1
Dumontet, J; Ensom, MH; Seto, K1
Ahlbrand, R; Bronson, SL; Horn, P; McNamara, RK; Richtand, NM; Stanford, K1
Cho, HY; Kang, HA; Lee, IK; Lee, SN; Lee, YB; Yoo, HD1
Cole-Strauss, A; Jandacek, R; Lipton, JW; McNamara, RK; Rider, T; Tso, P1
Calarge, CA; Miller, del D1
Boonleang, J; Mahatthanatrakul, W; Pipatrattanaseree, W; Ridtitid, W; Rujimamahasan, N; Sriwiriyajan, S; Wongnawa, M1
Andel, R; Becker, MA; Boaz, TL; Chandler, K; Desmarais, SL; Howe, A; Van Dorn, RA1
Cai, HL; Li, HD; Li, LF; Zhang, J; Zhu, RH1
Ahlbrand, R; Bronson, SL; Gudelsky, G; Kern, JR; Richtand, NM; Roenker, NL; Waterman, H1
Alphs, L; Bossie, CA; Ma, YW; Sliwa, JK1
Eerdekens, M; Fleischhacker, WW; Gassmann-Mayer, C; Gopal, S; Hough, D; Lane, R; Lim, P; Remmerie, B1
Conley, RR; Fijal, BA; Hoffmann, VP; Houston, JP; Kinon, BJ; Stauffer, VL; Witte, MM; Zhao, F1
Fujii, A; Kaneko, S; Nakagami, T; Saito, M; Sugawara, N; Tsuchimine, S; Yasui-Furukori, N1
Bernardo, M; Gassó, P; Lafuente, A; Mas, S; Molina, O; Parellada, E1
Albuquerque, NC; Borges, KB; Calixto, LA; de Gaitani, CM; de Jesus, LI; de Oliveira, AR; Furtado, NA; Pupo, MT; Simões, RA1
Liang, CS; Yang, FW1
Fukui, N; Inoue, Y; Ono, S; Saito, M; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J2
Citrome, L; Hochfeld, M; Meng, X; Stahl, SM1
DiCrescento, S; Perry, R; Wolberg, J1
Mori, T1
Howell, LL; Muly, EC; Ritchie, J; Votaw, JR1
Lane, HY; Teng, PR1
Singh, D; Williams, O1
Bies, RR; Mamo, DC; Mimura, M; Pollock, BG; Suzuki, T; Tsunoda, K; Uchida, H; Watanabe, K1
Danhof, M; de Greef, R; Grimwood, S; Groothuis, GM; Johnson, M; Kozielska, M; Li, C; Pilla Reddy, V; Proost, JH; Vermeulen, A1
Knoepflmacher, D; Shapley, L; Turner, EH1
Martin, M; McGuire, A; Mehnert, A; Nicholl, D; Pudas, H1
Chung, TS; Lung, FW1
Bowskill, SV; Fisher, DS; Flanagan, RJ; Handley, SA; Patel, MX1
Chung, YC; Kim, MG; Oh, KY; Park, MS; Park, TW; Yang, JC; Yoon, KS1
Cho, HY; Lee, SN; Lee, YB; Yoo, HD; Yoon, H1
Citrome, L1
Haga, T; Hashizume, T; Inoue, T; Katsumata, T; Ogawa, Y; Osada, K; Sogame, Y; Tagawa, M; Taguchi, A; Watanabe, T; Yabuki, M; Yamaguchi, N1
Nussbaum, AM; Stroup, TS1
Bae, KY; Chung, YC; Kim, JM; Kim, SW; Kim, SY; Lee, JH; Lee, YH; Shin, IS; Yoon, JS1
Bocato, MZ; Calixto, LA; de Gaitani, CM; de Oliveira, AR; Pupo, MT; Simões, RA1
Doran, AC; Mancuso, JY; Osgood, SM; Shaffer, CL1
Aman, MG; Bies, RR; Saldaña, SN; Sherwin, CM; Vinks, AA1
Den, R; Hirano, J; Ikai, S; Mamo, D; Mimura, M; Nishimoto, M; Remington, G; Suzuki, T; Takeuchi, H; Tsuboi, T; Tsunoda, K; Uchida, H; Watanabe, K1
Druitt, T; Dunsdon, J; Purushothaman, S; Raj, V1
Butzbach, DM; Byard, RW; Kobus, HJ; Lokan, RJ; Sims, DN; Stockham, PC; Walker, GS1
Kandasamy, A1
Baandrup, L; Glenthoj, B; Jennum, P; Lublin, H1
Chae, SW; Choi, JM; Lee, HJ; Lee, KS; Park, JH; Rhie, SJ1
Franch, J; Labad, J; López, X; Monseny, R; Montalvo, I; Ortega, L; Solé, M; Vilella, E1
Boot, AM; Buitelaar, JK; Roke, Y; Tenback, D; van Harten, PN1
Andrade, C; Suresh Kumar, PN1
Carano, A; Cavuto, M; De Berardis, D; Di Giannantonio, M; Fornaro, M; Iasevoli, F; Lang, AP; Marini, S; Martinotti, G; Mazza, M; Perna, G; Piersanti, M; Valchera, A1
Campistol, J; Darling, A; Perez-Duenas, B; Poo, P1
Baseman, A; Berlin, JA; Gopal, S; Hough, D; Karcher, K; Kent, J; Nuamah, I; Palumbo, J; Xu, Y1
Gen, K; Hibino, H; Inoue, Y; Matsumoto, H; Mikami, A; Mikami, K; Otomo, M; Suzuki, H2
Alphs, L; Bossie, CA; Fu, DJ; Kern Sliwa, J; Ma, YW2
Couchman, L; Fisher, DS; Flanagan, RJ; Handley, SA; Morgan, PE; Partridge, SJ1
Kirk Morton, N; Zubek, D1
Fisher, DS; Flanagan, RJ; Handley, SA; Partridge, SJ1
Medvedovici, A; Rădulescu, FŞ; Ranetti, AE; Voicu, V1
Fukui, N; Ono, S; Saito, M; Someya, T; Sugai, T; Suzuki, Y; Tsuneyama, N; Watanabe, J1
Sakai, A; Sanjo, K; Takeuchi, K1
Ahn, YM; Chang, SM; Joo, EJ; Kim, EY; Kim, JJ; Kim, YS; Shim, JC1
Einarson, TR; Garg, M; Hemels, ME; Skoupá, J; Veselá, S; Zilbershtein, R1
Berg, KA; Chavera, TA; Clarke, WP; Silva, M; Sullivan, LC1
Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R1
Boot, AM; Buitelaar, JK; Franke, B; Galesloot, TE; Roke, Y; van Harten, PN1
Fudala, PJ; Gomeni, R; Heidbreder, C; Nasser, AF1
D'Souza, S; DeLuca, P; Faraj, J1
Gen, K; Hibino, H; Inoue, Y; Matsumoto, H; Mikami, A; Mikami, K; Suzuki, H1
Alphs, L; Bossie, CA; Fu, DJ; Ma, YW; Sliwa, JK1
Kmietowicz, Z1
Bø, CN; Einarson, TR; Hemels, ME; Jensen, R; Piwko, C; Pudas, H; Vicente, C; Zilbershtein, R1
Aboul-Fotouh, S; Elgayar, N1
Appolinário, JC; Bressan, RA; Campos, JA; de Oliveira, IR; Elkis, H; Gattaz, WF; Grabowski, HM; Henna, E; Lacerda, AL; Lawson, FL; Louzã, MR; Périco, Cde A; Quevedo, J; Rocha, FL; Ruschel, SI; Sacomani, E; Zorzetto Filho, D1
Kwak, KH; Lee, SJ; Lim, MS; Seong, SJ; Yang, DS; Yoon, YR1
Fudala, PJ; Gomeni, R; Heidbreder, C; Laffont, CM; Nasser, AF; Zheng, B2
Alva, G; Brams, M; Citrome, L; Glick, ID; Hochfeld, M; Jackson, R; Kianifard, F; Mattingly, G; Meng, X; Pestreich, L; Weiden, PJ; Winseck, A1
Jayathilake, K; Johnson, R; Kwentus, J; Lindenmayer, JP; Meltzer, HY; Share, DB1
Hou, YC; Lai, CH1
Barton, HA; Danhof, M; de Greef, R; Grimwood, S; Groothuis, GM; Johnson, M; Kozielska, M; Pilla Reddy, V; Proost, JH; Vermeulen, A1
Budman, CL1
Morrissette, DA; Stahl, SM1
Alva, G; Citrome, L; Glick, ID; Jackson, R; Kianifard, F; Mattingly, G; Meng, X; Weiden, PJ; Winseck, A1
Buchanan, RW; Carpenter, WT1
Bieńkowski, P; Jastrzębska-Więsek, M; Kołaczkowski, M; Mierzejewski, P; Partyka, A; Wasik, A; Wesołowska, A1
Fabbri, C; Kato, M; Kinoshita, T; Koshikawa, Y; Nishida, K; Onohara, A; Sakai, S; Serretti, A; Sunada, N; Takekita, Y; Yoshimura, M1
Baymeeva, NV; Kaleda, VG; Miroshnichenko, II; Platova, AI1
Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S1
Fu, K; He, Y; Jiang, W; Liu, W; Lu, J; Wang, Z; Wu, R; Xu, Y; Yan, Y; Yang, Y; Zhao, J1
Dai, G; Geng, L; Gu, H; Teng, Z; Xu, W1

Reviews

57 review(s) available for isoxazoles and risperidone

ArticleYear
New antipsychotics: classification, efficacy, and adverse effects.
    Schizophrenia bulletin, 1991, Volume: 17, Issue:2

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride

1991
Ethical issues in drug selection for schizophrenia.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1993, Volume: 38 Suppl 3

    Topics: Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Ethics, Medical; Humans; Informed Consent; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology

1993
New antipsychotic medications: do research results relate to clinical practice?
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1993, Volume: 38 Suppl 3

    Topics: Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Dyskinesia, Drug-Induced; Humans; Isoxazoles; Neurologic Examination; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

1993
Pharmacological profile of risperidone.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1993, Volume: 38 Suppl 3

    Topics: Antipsychotic Agents; Brain; Dose-Response Relationship, Drug; Haloperidol; Humans; Isoxazoles; Metabolic Clearance Rate; Piperidines; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology

1993
Clinical review of risperidone.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1993, Volume: 38 Suppl 3

    Topics: Antipsychotic Agents; Clinical Trials, Phase III as Topic; Humans; Isoxazoles; Multicenter Studies as Topic; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology

1993
Clinical considerations in the use of risperidone.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1993, Volume: 38 Suppl 3

    Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology

1993
Newer antipsychotic drugs. A review of their pharmacology and therapeutic potential.
    Drugs, 1993, Volume: 46, Issue:4

    Topics: Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Piperidines; Remoxipride; Risperidone; Schizophrenia; Treatment Outcome

1993
Risperidone.
    Lancet (London, England), 1994, Feb-19, Volume: 343, Issue:8895

    Topics: Antipsychotic Agents; Drug Interactions; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1994
The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 164, Issue:2

    Topics: Antipsychotic Agents; Brain; Clozapine; Dyskinesia, Drug-Induced; Extrapyramidal Tracts; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
Risperidone: clinical issues in treatment.
    Journal of psychosocial nursing and mental health services, 1994, Volume: 32, Issue:5

    Topics: Antipsychotic Agents; Drug Approval; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

1994
Extrapyramidal side effects and tolerability of risperidone: a review.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Dystonia; Haloperidol; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1994
Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Clozapine; Dopamine Antagonists; Drug Therapy, Combination; Female; Fluvoxamine; Haloperidol; Humans; Isoxazoles; Male; Obsessive-Compulsive Disorder; Piperidines; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tic Disorders; Tourette Syndrome

1994
The potential benefits of serotonin receptor-specific agents.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Humans; Isoxazoles; Ondansetron; Piperazines; Piperidines; Receptors, Serotonin; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Sumatriptan; Triazoles

1994
The effects of clozapine on neurocognition: an overview.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl B

    Topics: Clozapine; Cognition; Cognition Disorders; Dopamine; Humans; Isoxazoles; Neuropsychological Tests; Piperidines; Receptors, Dopamine; Receptors, Muscarinic; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

1994
Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.
    Drugs, 1994, Volume: 48, Issue:2

    Topics: Absorption; Adult; Aged; Aging; Animals; Antipsychotic Agents; Central Nervous System; Cross-Over Studies; Disease Models, Animal; Drug Interactions; Hemodynamics; Humans; Isoxazoles; Neurosecretory Systems; Piperidines; Risperidone; Schizophrenia; Synaptic Transmission; Tissue Distribution

1994
Survey on the pharmacodynamics of the new antipsychotic risperidone.
    Psychopharmacology, 1994, Volume: 114, Issue:1

    Topics: Animals; Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Risperidone; Serotonin Antagonists

1994
Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1994, Volume: 39, Issue:9 Suppl 2

    Topics: Antipsychotic Agents; Brain; Clinical Trials as Topic; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
Pathophysiology and treatment of negative symptoms.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1994, Volume: 39, Issue:9 Suppl 2

    Topics: Antipsychotic Agents; Brain; Depression; Dose-Response Relationship, Drug; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
Pharmacotherapy of schizophrenia: a review.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1994, Volume: 39, Issue:9 Suppl 2

    Topics: Antipsychotic Agents; Brain; Clozapine; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
Recent advances in the pharmacotherapy of schizophrenia.
    Acta psychiatrica Scandinavica. Supplementum, 1994, Volume: 384

    Topics: Adult; Antipsychotic Agents; Brain; Clozapine; Dopamine; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1994
Risperidone: review of its pharmacology and therapeutic use in schizophrenia.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1994, Volume: 6, Issue:3

    Topics: Antipsychotic Agents; Clinical Trials as Topic; Humans; Isoxazoles; Piperidines; Placebos; Risperidone; Schizophrenia; Treatment Outcome

1994
[New psychopharmacologic alternatives in treatment of schizophrenia].
    Schweizer Archiv fur Neurologie und Psychiatrie (Zurich, Switzerland : 1985), 1994, Volume: 145, Issue:6

    Topics: Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Isoxazoles; Piperidines; Psychotropic Drugs; Remoxipride; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:1 Suppl 1

    Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dopamine Antagonists; Humans; Imidazoles; Indoles; Isoxazoles; Olanzapine; Piperidines; Pirenzepine; Risperidone; Schizophrenia; Serotonin Antagonists

1995
Brief comparison of the pharmacokinetics and pharmacodynamics of the traditional and newer antipsychotic drugs.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Feb-01, Volume: 52, Issue:3 Suppl 1

    Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Haloperidol; Humans; Isoxazoles; Piperidines; Risperidone; Time Factors

1995
Clinical use of the newer antipsychotic drugs.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Feb-01, Volume: 52, Issue:3 Suppl 1

    Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Female; Formularies as Topic; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia

1995
A risk-benefit assessment of risperidone in schizophrenia.
    Drug safety, 1995, Volume: 12, Issue:2

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Risk; Risperidone; Schizophrenia

1995
Serotonin, schizophrenia and antipsychotic drug action.
    Schizophrenia research, 1995, Volume: 14, Issue:3

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Humans; Isoxazoles; Piperazines; Piperidines; Risperidone; Schizophrenia; Serotonin; Tryptophan

1995
Prospects for pharmacotherapy of schizophrenia.
    Lancet (London, England), 1995, Mar-04, Volume: 345, Issue:8949

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia

1995
The negative component in schizophrenia.
    Acta psychiatrica Scandinavica. Supplementum, 1995, Volume: 388

    Topics: Affective Symptoms; Antipsychotic Agents; Haloperidol; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Risperidone; Schizophrenia; Schizophrenic Psychology

1995
New pharmacotherapeutic modalities for negative symptoms in psychosis.
    Acta psychiatrica Scandinavica. Supplementum, 1995, Volume: 388

    Topics: Affective Symptoms; Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Risperidone; Schizophrenia; Schizophrenic Psychology; Syndrome

1995
Long-term treatment of mood disorders in schizophrenia.
    Acta psychiatrica Scandinavica. Supplementum, 1995, Volume: 388

    Topics: Affective Symptoms; Antidepressive Agents; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Isoxazoles; Lithium; Long-Term Care; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology

1995
Principal components and further possibilities with the PANSS.
    Acta psychiatrica Scandinavica. Supplementum, 1995, Volume: 388

    Topics: Affective Symptoms; Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Risperidone; Schizophrenia; Schizophrenic Psychology; Syndrome

1995
Antipsychotic medication in the treatment of schizophrenia.
    The Israel journal of psychiatry and related sciences, 1995, Volume: 32, Issue:1

    Topics: Antipsychotic Agents; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology

1995
A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors.
    International clinical psychopharmacology, 1995, Volume: 10, Issue:1

    Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Humans; Isoxazoles; Piperidines; Risperidone; Serotonin Antagonists

1995
Risperidone: review and assessment of its role in the treatment of schizophrenia.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:6

    Topics: Antipsychotic Agents; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1995
Treatment of schizophrenia.
    Lancet (London, England), 1995, Sep-23, Volume: 346, Issue:8978

    Topics: Antipsychotic Agents; Behavior Therapy; Clozapine; Cognitive Behavioral Therapy; Family Therapy; Humans; Isoxazoles; Piperidines; Psychotherapy; Rehabilitation, Vocational; Risperidone; Schizophrenia

1995
Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.
    CNS drugs, 2002, Volume: 16, Issue:4

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dosage Forms; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quinolones; Risperidone; Schizophrenia; Thiazoles

2002
Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
    Clinical therapeutics, 2007, Volume: 29, Issue:2

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Chemistry, Pharmaceutical; Clinical Trials, Phase I as Topic; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Patient Compliance; Patient Satisfaction; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Solubility; Tablets; Taste; Therapeutic Equivalency

2007
Forty years of antipsychotic Drug research--from haloperidol to paliperidone--with Dr. Paul Janssen.
    Arzneimittel-Forschung, 2007, Volume: 57, Issue:10

    Topics: Antipsychotic Agents; Haloperidol; History, 20th Century; History, 21st Century; Humans; Isoxazoles; Paliperidone Palmitate; Pimozide; Psychotic Disorders; Pyrimidines; Risperidone; Structure-Activity Relationship

2007
Paliperidone for schizophrenia.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Mar-01, Volume: 65, Issue:5

    Topics: Antipsychotic Agents; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Drug Interactions; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia

2008
Paliperidone for schizophrenia.
    The Cochrane database of systematic reviews, 2008, Apr-16, Issue:2

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia

2008
Expected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release.
    Expert opinion on drug delivery, 2009, Volume: 6, Issue:3

    Topics: Antipsychotic Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome

2009
Akathisia and second-generation antipsychotic drugs.
    Current opinion in psychiatry, 2009, Volume: 22, Issue:3

    Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles

2009
Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory schizophrenia: overview of systematic reviews.
    Sao Paulo medical journal = Revista paulista de medicina, 2010, Volume: 128, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Humans; Isoxazoles; Meta-Analysis as Topic; Paliperidone Palmitate; Piperazines; Placebos; Pyrimidines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Review Literature as Topic; Risperidone; Schizophrenia; Treatment Outcome

2010
Risperidone in schizophrenia: is there a role for therapeutic drug monitoring?
    Therapeutic drug monitoring, 2011, Volume: 33, Issue:3

    Topics: Antipsychotic Agents; Drug Monitoring; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia

2011
Oral paliperidone extended-release: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability.
    Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:7

    Topics: Administration, Oral; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Half-Life; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia

2012
Paliperidone palmitate for schizophrenia.
    The Cochrane database of systematic reviews, 2012, Jun-13, Issue:6

    Topics: Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia

2012
Second-generation long-acting injectable antipsychotic agents: an overview.
    Drug and therapeutics bulletin, 2012, Volume: 50, Issue:9

    Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Drug Costs; Humans; Injections; Isoxazoles; Monitoring, Physiologic; Olanzapine; Paliperidone Palmitate; Practice Guidelines as Topic; Pyrimidines; Risperidone; Schizophrenia

2012
Treatment options for residual insomnia in schizophrenia.
    Acta psychiatrica Scandinavica, 2013, Volume: 127, Issue:1

    Topics: Antipsychotic Agents; Central Nervous System Depressants; Humans; Isoxazoles; Melatonin; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Sleep Initiation and Maintenance Disorders

2013
Efficacy and safety of long acting injectable atypical antipsychotics: a review.
    Current clinical pharmacology, 2013, Volume: 8, Issue:3

    Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Drug Delivery Systems; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia

2013
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
    Revista de neurologia, 2013, Feb-01, Volume: 56, Issue:3

    Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid

2013
Risk of cardiovascular morbidity with risperidone or paliperidone treatment: analysis of 64 randomized, double-blind trials.
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:2

    Topics: Antipsychotic Agents; Cardiovascular Diseases; Databases, Factual; Drug Labeling; Humans; Incidence; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Risk; Risperidone

2013
Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences.
    Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:8

    Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Blood-Brain Barrier; Humans; Hyperprolactinemia; Isoxazoles; Paliperidone Palmitate; Piperazines; Prolactin; Pyrimidines; Quinolones; Receptors, Dopamine D2; Risperidone; Stress, Psychological; Sulpiride; Xenobiotics

2013
[Paliperidone, risperidone].
    Nihon rinsho. Japanese journal of clinical medicine, 2013, Volume: 71, Issue:4

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Japan; Paliperidone Palmitate; Pyrimidines; Receptor, Serotonin, 5-HT2A; Risperidone; Schizophrenia; Treatment Outcome

2013
The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.
    Drugs, 2014, Volume: 74, Issue:11

    Topics: Antipsychotic Agents; Aripiprazole; Clinical Trials as Topic; Humans; Isoxazoles; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Tourette Syndrome; Treatment Outcome

2014
Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.
    CNS spectrums, 2014, Volume: 19, Issue:5

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Dibenzocycloheptenes; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Impulsive Behavior; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Thiazoles; Violence

2014
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
    The American journal of psychiatry, 2020, 04-01, Volume: 177, Issue:4

    Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes

2020

Trials

105 trial(s) available for isoxazoles and risperidone

ArticleYear
The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability.
    Acta psychiatrica Scandinavica, 1992, Volume: 86, Issue:6

    Topics: Antipsychotic Agents; Chronic Disease; Cross-Cultural Comparison; Double-Blind Method; Haloperidol; Humans; Isoxazoles; Observer Variation; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Risperidone; Schizophrenia; Schizophrenic Psychology; Sweden

1992
Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study.
    Acta psychiatrica Scandinavica, 1992, Volume: 85, Issue:4

    Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Female; Haloperidol; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology

1992
Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients.
    Acta psychiatrica Scandinavica, 1992, Volume: 85, Issue:4

    Topics: Adult; Aged; Antipsychotic Agents; Brain; Cerebral Ventricles; Chronic Disease; Dilatation, Pathologic; Double-Blind Method; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Tomography, X-Ray Computed

1992
Risperidone, a new antipsychotic with serotonin 5-HT2 and dopamine D2 antagonistic properties.
    Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A

    Topics: Antipsychotic Agents; Dopamine Antagonists; Double-Blind Method; Electrocardiography; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Risperidone; Schizophrenia; Serotonin Antagonists

1992
Risperidone in the treatment of chronic schizophrenic patients: an international double-blind parallel-group study versus haloperidol. The International Risperidone Research Group.
    Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A

    Topics: Antipsychotic Agents; Double-Blind Method; Haloperidol; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology

1992
Risperidone: clinical development: north American results.
    Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Humans; Isoxazoles; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia

1992
Risperidone: clinical safety and efficacy in schizophrenia.
    Psychopharmacology bulletin, 1992, Volume: 28, Issue:2

    Topics: Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology

1992
Pilot clinical investigation of risperidone in the treatment of psychotic patients.
    Pharmacopsychiatry, 1990, Volume: 23, Issue:5

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Evaluation; Female; Humans; Isoxazoles; Male; Middle Aged; Pilot Projects; Piperidines; Psychotic Disorders; Risperidone

1990
New antipsychotics: classification, efficacy, and adverse effects.
    Schizophrenia bulletin, 1991, Volume: 17, Issue:2

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride

1991
Thymosthenic agents, a novel approach in the treatment of schizophrenia.
    The British journal of psychiatry. Supplement, 1989, Issue:5

    Topics: Brain; Butyrophenones; Humans; Isoxazoles; Piperidines; Pyrimidinones; Randomized Controlled Trials as Topic; Receptors, Serotonin; Risperidone; Ritanserin; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists

1989
Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations.
    Acta psychiatrica Scandinavica, 1993, Volume: 88, Issue:6

    Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Denmark; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Norway; Parkinson Disease, Secondary; Perphenazine; Piperidines; Prevalence; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index

1993
Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: a double blind, randomized trial.
    Progress in neuro-psychopharmacology & biological psychiatry, 1994, Volume: 18, Issue:1

    Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Double-Blind Method; Electrocardiography; Electroencephalography; Female; Humans; Infant, Newborn; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia, Paranoid

1994
Risperidone in the treatment of schizophrenia.
    The American journal of psychiatry, 1994, Volume: 151, Issue:6

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Placebos; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

1994
Symptoms in schizophrenic syndromes in relation to age, sex, duration of illness and number of previous hospitalizations.
    Acta psychiatrica Scandinavica, 1994, Volume: 89, Issue:4

    Topics: Adult; Age Factors; Age of Onset; Aged; Antipsychotic Agents; Female; Haloperidol; Hospitalization; Hospitals, Psychiatric; Humans; Isoxazoles; Male; Middle Aged; Patient Admission; Piperidines; Risperidone; Ritanserin; Schizophrenia; Schizophrenic Psychology; Sex Factors

1994
Efficacy of risperidone on positive features of schizophrenia.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Adult; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Haloperidol; Humans; Isoxazoles; Piperidines; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Treatment Outcome

1994
Negative symptoms in schizophrenia: assessment of the effect of risperidone.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia; Single-Blind Method

1994
Changes in single symptoms and separate factors of the schizophrenic syndrome after treatment with risperidone or haloperidol.
    Pharmacopsychiatry, 1994, Volume: 27, Issue:3

    Topics: Double-Blind Method; Haloperidol; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1994
Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.
    Drugs, 1994, Volume: 48, Issue:2

    Topics: Absorption; Adult; Aged; Aging; Animals; Antipsychotic Agents; Central Nervous System; Cross-Over Studies; Disease Models, Animal; Drug Interactions; Hemodynamics; Humans; Isoxazoles; Neurosecretory Systems; Piperidines; Risperidone; Schizophrenia; Synaptic Transmission; Tissue Distribution

1994
Desmopressin for risperidone-induced enuresis.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1994, Volume: 6, Issue:2

    Topics: Administration, Intranasal; Adult; Antipsychotic Agents; Deamino Arginine Vasopressin; Double-Blind Method; Enuresis; Female; Haloperidol; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone.
    Psychopharmacology, 1993, Volume: 110, Issue:3

    Topics: Adult; Antipsychotic Agents; Brain Chemistry; Cerebellum; Cerebral Cortex; Dopamine Antagonists; Humans; Isoxazoles; Male; Piperidines; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Tomography, Emission-Computed

1993
Pharmacokinetics of risperidone in chronic schizophrenic patients.
    Psychopharmacology bulletin, 1994, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Cross-Over Studies; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia; Therapeutic Equivalency

1994
Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.
    Progress in neuro-psychopharmacology & biological psychiatry, 1994, Volume: 18, Issue:7

    Topics: Adult; Antipsychotic Agents; Clozapine; Drug Resistance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Risperidone; Schizophrenia; Schizophrenic Psychology; Sex Characteristics

1994
Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.
    Psychopharmacology, 1995, Volume: 117, Issue:1

    Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benzamides; Cerebral Cortex; Dopamine D2 Receptor Antagonists; Female; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Isoxazoles; Male; Middle Aged; Neostriatum; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Remoxipride; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon

1995
Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:1 Suppl 1

    Topics: Adult; Analysis of Variance; Antipsychotic Agents; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia

1995
Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:1 Suppl 1

    Topics: Adult; Antipsychotic Agents; Clozapine; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology

1995
A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study.
    European archives of psychiatry and clinical neuroscience, 1995, Volume: 245, Issue:1

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Haloperidol; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1995
The negative component in schizophrenia.
    Acta psychiatrica Scandinavica. Supplementum, 1995, Volume: 388

    Topics: Affective Symptoms; Antipsychotic Agents; Haloperidol; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Risperidone; Schizophrenia; Schizophrenic Psychology

1995
New pharmacotherapeutic modalities for negative symptoms in psychosis.
    Acta psychiatrica Scandinavica. Supplementum, 1995, Volume: 388

    Topics: Affective Symptoms; Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Risperidone; Schizophrenia; Schizophrenic Psychology; Syndrome

1995
Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial.
    Acta psychiatrica Scandinavica, 1995, Volume: 91, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Clopenthixol; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology

1995
Critique of the Canadian Multicenter Placebo-Controlled Study of Risperidone and Haloperidol.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:3

    Topics: Canada; Double-Blind Method; Haloperidol; Humans; Isoxazoles; Piperidines; Research Design; Risperidone; Schizophrenia

1995
Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group.
    The British journal of psychiatry : the journal of mental science, 1995, Volume: 166, Issue:6

    Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Isoxazoles; Male; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology

1995
Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
    The Journal of clinical psychiatry, 1995, Volume: 56, Issue:9

    Topics: Adult; Ambulatory Care; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome

1995
A PET study of D2 and 5-HT2 receptor occupancy induced by risperidone in poor metabolizers of debrisoquin and risperidone.
    Psychopharmacology, 1995, Volume: 119, Issue:3

    Topics: Adult; Antipsychotic Agents; Debrisoquin; Genotype; Humans; Isoxazoles; Male; Piperidines; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Tomography, Emission-Computed

1995
Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study.
    Acta psychiatrica Scandinavica, 1993, Volume: 87, Issue:3

    Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Isoxazoles; Male; Mental Disorders; Middle Aged; Piperidines; Placebos; Risperidone

1993
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:1

    Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Neurologic Examination; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology

1993
Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: a parallel group double-blind comparative trial.
    Yonsei medical journal, 1993, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Chronic Disease; Double-Blind Method; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia

1993
Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
    Journal of clinical psychopharmacology, 1993, Volume: 13, Issue:5

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Dominance, Cerebral; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Evoked Potentials; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Behavior

1993
Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Pharmacopsychiatry, 1993, Volume: 26, Issue:4

    Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Female; Haloperidol; Humans; Isoxazoles; Male; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology

1993
Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detection.
    Pharmacopsychiatry, 1998, Volume: 31, Issue:3

    Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia

1998
Serum concentrations and side effects in psychiatric patients during risperidone therapy.
    Therapeutic drug monitoring, 1998, Volume: 20, Issue:4

    Topics: Adult; Aged; Antipsychotic Agents; Cross-Sectional Studies; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotropic Drugs; Pyrimidines; Risperidone

1998
Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone.
    Psychopharmacology, 1999, Volume: 147, Issue:3

    Topics: Adult; Alleles; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Pyrimidines; Risperidone; Schizophrenia

1999
Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1999, Volume: 10, Issue:1

    Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Depression; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Isoxazoles; Male; Mianserin; Middle Aged; Mirtazapine; Paliperidone Palmitate; Pilot Projects; Psychotic Disorders; Pyrimidines; Risperidone; Severity of Illness Index; Treatment Outcome

1999
Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia.
    Journal of pharmaceutical and biomedical analysis, 1999, Volume: 19, Issue:3-4

    Topics: Adult; Aged; Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Female; Humans; Isoxazoles; Japan; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Schizophrenia; Sensitivity and Specificity

1999
Risperidone in acutely exacerbated schizophrenia: dosing strategies and plasma levels.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:3

    Topics: Acute Disease; Adult; Antipsychotic Agents; Asian People; Drug Administration Schedule; Female; Hospitalization; Humans; Isoxazoles; Male; Paliperidone Palmitate; Patient Readmission; Pharmacogenetics; Prospective Studies; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Taiwan; Treatment Outcome

2000
Effect of risperidone on plasma free 3-methoxy-4-hydroxyphenylglycol (pMHPG) levels in schizophrenic patients: relationship among plasma concentrations of risperidone and 9-hydroxyrisperidone, pMHPG levels, and clinical improvement.
    International clinical psychopharmacology, 2000, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Serotonin Antagonists; Treatment Outcome

2000
Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia.
    Psychopharmacology, 2001, Jan-01, Volume: 153, Issue:2

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chromatography, High Pressure Liquid; Chronic Disease; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology

2001
Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together.
    Journal of clinical pharmacology, 2002, Volume: 42, Issue:12

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Area Under Curve; Biological Availability; Cholinesterase Inhibitors; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Female; Galantamine; Gas Chromatography-Mass Spectrometry; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Time Factors

2002
Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers.
    Clinical therapeutics, 2003, Volume: 25, Issue:6

    Topics: Adult; Antipsychotic Agents; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Paliperidone Palmitate; Pyrimidines; Radioimmunoassay; Risperidone; Tablets; Therapeutic Equivalency; Time Factors

2003
Correlation between scores on Continuous Performance Test and plasma concentration for schizophrenic patients on risperidone.
    Psychiatry and clinical neurosciences, 2004, Volume: 58, Issue:2

    Topics: Adult; Antipsychotic Agents; Attention; Brief Psychiatric Rating Scale; Discrimination Learning; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Male; Neurologic Examination; Neuropsychological Tests; Paliperidone Palmitate; Pattern Recognition, Visual; Psychometrics; Psychomotor Performance; Pyrimidines; Reaction Time; Risperidone; Schizophrenia; Schizophrenic Psychology; Statistics as Topic; Treatment Outcome

2004
Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.
    Journal of child and adolescent psychopharmacology, 2004,Spring, Volume: 14, Issue:1

    Topics: Autistic Disorder; Child; Child, Preschool; Drug Tolerance; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Statistics, Nonparametric; Weight Gain

2004
Plasma risperidone concentrations during combined treatment with sertraline.
    Therapeutic drug monitoring, 2004, Volume: 26, Issue:4

    Topics: Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline

2004
Risperidone plasma levels, clinical response and side-effects.
    European archives of psychiatry and clinical neuroscience, 2005, Volume: 255, Issue:4

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prospective Studies; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia

2005
Serum concentrations of risperidone and 9-hydroxyrisperidone after administration of the long-acting injectable form of risperidone: evidence from a routine therapeutic drug monitoring service.
    Therapeutic drug monitoring, 2005, Volume: 27, Issue:1

    Topics: Administration, Oral; Adult; Aged; Delayed-Action Preparations; Drug Administration Schedule; Drug Monitoring; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia

2005
Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia.
    The international journal of neuropsychopharmacology, 2005, Volume: 8, Issue:1

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Binding, Competitive; Brain; Delayed-Action Preparations; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Image Processing, Computer-Assisted; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Positron-Emission Tomography; Pyrimidines; Radioimmunoassay; Receptors, Dopamine D2; Risperidone; Schizophrenia; Scintillation Counting

2005
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition.
    Clinical pharmacology and therapeutics, 2005, Volume: 78, Issue:1

    Topics: Administration, Oral; Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Chromatography, Liquid; Cross-Over Studies; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Drug Synergism; Genotype; Half-Life; Humans; Immunoenzyme Techniques; Isoxazoles; Japan; Male; Paliperidone Palmitate; Patient Selection; Prolactin; Pyrimidines; Risperidone; Statistics as Topic; Verapamil

2005
Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients.
    Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Schizophrenia

2005
Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients.
    Clinical pharmacology and therapeutics, 2005, Volume: 78, Issue:5

    Topics: Adult; Antifungal Agents; Antipsychotic Agents; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Genotype; Half-Life; Humans; Isoxazoles; Itraconazole; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia

2005
Pharmacokinetics and bioequivalence evaluation of risperidone in healthy male subjects with different CYP2D6 genotypes.
    Archives of pharmacal research, 2006, Volume: 29, Issue:6

    Topics: Administration, Oral; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Genotype; Humans; Isoxazoles; Korea; Male; Paliperidone Palmitate; Polymorphism, Single Nucleotide; Pyrimidines; Risperidone; Solubility; Tablets; Therapeutic Equivalency

2006
Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder.
    Journal of pharmacokinetics and pharmacodynamics, 2007, Volume: 34, Issue:2

    Topics: Acute Disease; Administration, Oral; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Computer Simulation; Cytochrome P-450 CYP2D6; Databases as Topic; Drug Administration Schedule; Female; Humans; Isoxazoles; Linear Models; Male; Middle Aged; Models, Biological; Paliperidone Palmitate; Phenotype; Population Surveillance; Pyrimidines; Reproducibility of Results; Risperidone; Tablets

2007
Prolactin release in children treated with risperidone: impact and role of CYP2D6 metabolism.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:1

    Topics: Adolescent; Age Factors; Antipsychotic Agents; Child; Child Development Disorders, Pervasive; Child, Preschool; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Prolactin; Prospective Studies; Pyrimidines; Risperidone

2007
A study of genetic (CYP2D6 and ABCB1) and environmental (drug inhibitors and inducers) variables that may influence plasma risperidone levels.
    Pharmacopsychiatry, 2007, Volume: 40, Issue:3

    Topics: Adult; Aging; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Female; Humans; Isoxazoles; Linear Models; Male; Middle Aged; Organic Anion Transporters; Paliperidone Palmitate; Pyrimidines; Risperidone; Sex Factors

2007
Lack of bioequivalence between generic risperidone oral solution and originator risperidone tablets.
    International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Confidence Intervals; Cross-Over Studies; Drugs, Generic; Female; Humans; Isoxazoles; Male; Mass Spectrometry; Middle Aged; Paliperidone Palmitate; Pharmaceutical Solutions; Pyrimidines; Risperidone; Tablets; Therapeutic Equivalency

2007
Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.
    Clinical therapeutics, 2007, Volume: 29, Issue:7

    Topics: Adolescent; Antipsychotic Agents; Area Under Curve; Child; Child, Preschool; Cytochrome P-450 CYP2D6; Developmental Disabilities; Female; Genotype; Half-Life; Humans; Isoxazoles; Male; Mental Disorders; Paliperidone Palmitate; Pyrimidines; Risperidone; Saliva

2007
Effect of rifampin, an inducer of CYP3A and P-glycoprotein, on the pharmacokinetics of risperidone.
    Journal of clinical pharmacology, 2008, Volume: 48, Issue:1

    Topics: Administration, Oral; Adult; Alleles; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Genotype; Half-Life; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Paliperidone Palmitate; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimidines; Rifampin; Risperidone; Time Factors

2008
Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone.
    International clinical psychopharmacology, 2008, Volume: 23, Issue:4

    Topics: Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia

2008
The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Female; Humans; Hyperprolactinemia; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Pyrimidines; Research Design; Risperidone; Schizophrenia; Schizophrenic Psychology

2008
Bioequivalence evaluation of two strengths of risperidone tablet formulations in healthy volunteers.
    International journal of clinical pharmacology and therapeutics, 2009, Volume: 47, Issue:2

    Topics: Adult; Antipsychotic Agents; Area Under Curve; Chromatography, Liquid; Cross-Over Studies; European Union; Female; Guidelines as Topic; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Tablets; Tandem Mass Spectrometry; Therapeutic Equivalency; Time Factors; United States; United States Food and Drug Administration; Young Adult

2009
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:7

    Topics: Adolescent; Adult; Antipsychotic Agents; Area Under Curve; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypotension, Orthostatic; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Young Adult

2010
Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone.
    International clinical psychopharmacology, 2010, Volume: 25, Issue:3

    Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Patient Satisfaction; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology

2010
Effect of CYP2D6, CYP3A5, and MDR1 genetic polymorphisms on the pharmacokinetics of risperidone and its active moiety.
    Journal of clinical pharmacology, 2010, Volume: 50, Issue:6

    Topics: Adult; Alleles; Antipsychotic Agents; Area Under Curve; Asian People; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Genotype; Humans; Isoxazoles; Male; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone

2010
Long-acting injectable risperidone and metabolic ratio: a possible index of clinical outcome in treatment-resistant schizophrenic patients.
    Psychopharmacology, 2010, Volume: 210, Issue:4

    Topics: Adolescent; Adult; Antipsychotic Agents; Biomarkers, Pharmacological; Brief Psychiatric Rating Scale; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Severity of Illness Index

2010
Gender differences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients.
    Progress in neuro-psychopharmacology & biological psychiatry, 2010, Oct-01, Volume: 34, Issue:7

    Topics: Adult; Aged; Chromatography, Liquid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Paliperidone Palmitate; Prolactin; Pyrimidines; Risperidone; Sex Characteristics; Tandem Mass Spectrometry; Young Adult

2010
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
    The Journal of clinical psychiatry, 2010, Volume: 71, Issue:11

    Topics: Adult; Antipsychotic Agents; Benzhydryl Compounds; Benzodiazepines; Central Nervous System Stimulants; Cognition Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Modafinil; Olanzapine; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome

2010
A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jan-15, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Double-Blind Method; Drug Delivery Systems; Female; Humans; Isoxazoles; Least-Squares Analysis; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Young Adult

2011
Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-Alzheimer's disease trial.
    Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Proportional Hazards Models; Pyrimidines; Risperidone; Time Factors; Treatment Outcome

2010
Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers.
    Clinical therapeutics, 2010, Volume: 32, Issue:12

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Area Under Curve; Biological Availability; Brazil; Chromatography, Liquid; Cross-Over Studies; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Tandem Mass Spectrometry; Therapeutic Equivalency

2010
Relative bioavailability and pharmacokinetic comparison of two 2-mg risperidone tablet formulations: A single dose, randomized-sequence, double-blind, 2-way crossover study in healthy male volunteers in Thailand.
    Clinical therapeutics, 2010, Volume: 32, Issue:10

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Biological Availability; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drugs, Generic; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Tablets; Thailand; Young Adult

2010
A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
    Progress in neuro-psychopharmacology & biological psychiatry, 2011, Jun-01, Volume: 35, Issue:4

    Topics: Adolescent; Adult; Antipsychotic Agents; Data Interpretation, Statistical; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Dyskinesia, Drug-Induced; Endpoint Determination; Female; Glucose; Heart Diseases; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Prolactin; Psychiatric Status Rating Scales; Risperidone; Sample Size; Schizophrenia; Schizophrenic Psychology; Suicide; Treatment Outcome; Young Adult

2011
Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10.
    British journal of pharmacology, 2011, Volume: 164, Issue:2b

    Topics: Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Cytochrome P-450 CYP2D6; Genotype; Humans; Isoxazoles; Male; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Retrospective Studies; Risperidone; Young Adult

2011
Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers.
    Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:2

    Topics: Adult; Antipsychotic Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Enzyme Inhibitors; Half-Life; Humans; Isoxazoles; Ketoconazole; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Tandem Mass Spectrometry; Tissue Distribution; Young Adult

2012
Effects of acute paliperidone palmitate treatment in subjects with schizophrenia recently treated with oral risperidone.
    Schizophrenia research, 2011, Volume: 132, Issue:1

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Palmitates; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome

2011
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia.
    The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:1

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Buttocks; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Sleep Initiation and Maintenance Disorders; Treatment Outcome; White People

2012
Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidone.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:3

    Topics: Adult; Antipsychotic Agents; Apoptosis Regulatory Proteins; Benzodiazepines; Biomarkers, Pharmacological; Black or African American; Drug Resistance; Genotype; Humans; Isoxazoles; Membrane Proteins; Membrane Transport Proteins; Olanzapine; Piperidines; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptors, AMPA; Risperidone; Schizophrenia; White People

2012
QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone.
    Human psychopharmacology, 2012, Volume: 27, Issue:1

    Topics: Adult; Age Factors; Antipsychotic Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Isoxazoles; Long QT Syndrome; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Young Adult

2012
Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Human psychopharmacology, 2012, Volume: 27, Issue:1

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperazines; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult

2012
Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study.
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Male; Middle Aged; Nonlinear Dynamics; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Young Adult

2012
Different impacts of aquaporin 4 and MAOA allele variation among olanzapine, risperidone, and paliperidone in schizophrenia.
    Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:3

    Topics: Adult; Antipsychotic Agents; Aquaporin 4; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Female; Genetic Association Studies; Humans; Isoxazoles; Male; Middle Aged; Monoamine Oxidase; Olanzapine; Paliperidone Palmitate; Polymorphism, Genetic; Promoter Regions, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Smoking; Young Adult

2012
Different safety profiles of risperidone and paliperidone extended-release: a double-blind, placebo-controlled trial with healthy volunteers.
    Human psychopharmacology, 2012, Volume: 27, Issue:3

    Topics: Adult; Analysis of Variance; Antipsychotic Agents; Chi-Square Distribution; Cognition; Double-Blind Method; Drug Administration Schedule; Drug Delivery Systems; Female; Humans; Isoxazoles; Male; Neuropsychological Tests; Pain Measurement; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Substance-Related Disorders; Time Factors

2012
Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1.
    Journal of pharmacokinetics and pharmacodynamics, 2012, Volume: 39, Issue:4

    Topics: Adult; Alleles; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cross-Over Studies; Cytochrome P-450 CYP2D6; Genotype; Humans; Isoxazoles; Male; Models, Biological; Paliperidone Palmitate; Polymorphism, Single Nucleotide; Pyrimidines; Risperidone; Young Adult

2012
Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial.
    International clinical psychopharmacology, 2012, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Antipsychotic Agents; Cognition Disorders; Delayed-Action Preparations; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Monitoring; Female; Humans; Isoxazoles; Male; Middle Aged; Movement Disorders; Paliperidone Palmitate; Prevalence; Psychiatric Status Rating Scales; Pyrimidines; Republic of Korea; Risperidone; Schizophrenia; Young Adult

2012
Study of the efficacy and safety of switching from risperidone to paliperidone in elderly patients with schizophrenia.
    Psychiatry and clinical neurosciences, 2013, Volume: 67, Issue:2

    Topics: Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Patient Satisfaction; Pyrimidines; Risperidone; Schizophrenia

2013
Paliperidone palmitate versus risperidone long-acting injection in markedly-to-severely ill schizophrenia subjects: onset of efficacy with recommended initiation regimens.
    Clinical schizophrenia & related psychoses, 2014, Volume: 8, Issue:2

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome

2014
Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents.
    Current medical research and opinion, 2013, Volume: 29, Issue:10

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prospective Studies; Pyrimidines; Risperidone; Schizophrenia; Severity of Illness Index

2013
A model-based approach to characterize the population pharmacokinetics and the relationship between the pharmacokinetic and safety profiles of RBP-7000, a new, long-acting, sustained-released formulation of risperidone.
    Journal of clinical pharmacology, 2013, Volume: 53, Issue:10

    Topics: Adolescent; Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Female; Humans; Injections, Subcutaneous; Isoxazoles; Male; Middle Aged; Models, Biological; Paliperidone Palmitate; Polyglactin 910; Prolactin; Pyrimidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Young Adult

2013
The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: a preliminary open-label trial.
    International journal of psychiatry in clinical practice, 2014, Volume: 18, Issue:1

    Topics: Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Cognition Disorders; Drug Substitution; Dyskinesia, Drug-Induced; Female; Humans; Isoxazoles; Male; Memory, Short-Term; Neuropsychological Tests; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome

2014
Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison.
    International clinical psychopharmacology, 2014, Volume: 29, Issue:1

    Topics: Adult; Age of Onset; Antipsychotic Agents; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Isoxazoles; Male; Muscle Rigidity; Paliperidone Palmitate; Palmitates; Prolactin; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome

2014
Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study.
    Current medical research and opinion, 2014, Volume: 30, Issue:4

    Topics: Administration, Oral; Adult; Delayed-Action Preparations; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Patient Satisfaction; Prospective Studies; Pyrimidines; Quality of Life; Risperidone; Schizophrenia; Severity of Illness Index

2014
Changes in plasma concentrations of risperidone and 9-hydroxyrisperidone and the associated clinical effects during the switch from oral risperidone to extended-release paliperidone tablets in patients with schizophrenia.
    Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:4

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Time Factors; Young Adult

2014
Population pharmacokinetics and prediction of dopamine D2 receptor occupancy after multiple doses of RBP-7000, a new sustained-release formulation of risperidone, in schizophrenia patients on stable oral risperidone treatment.
    Clinical pharmacokinetics, 2014, Volume: 53, Issue:6

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Injections, Subcutaneous; Isoxazoles; Male; Middle Aged; Models, Biological; Paliperidone Palmitate; Pyrimidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Young Adult

2014
A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia.
    Schizophrenia research, 2014, Volume: 153, Issue:1-3

    Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Aortic Bodies; Aripiprazole; Benzodiazepines; Cohort Studies; Drug Administration Schedule; Drug Substitution; Female; Humans; Isoxazoles; Male; Middle Aged; Olanzapine; Piperazines; Piperidines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Surveys and Questionnaires; Treatment Outcome; Young Adult

2014
A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia.
    Schizophrenia research, 2014, Volume: 154, Issue:1-3

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Time Factors; Treatment Outcome; Young Adult

2014
Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:7

    Topics: Antipsychotic Agents; Double-Blind Method; Humans; Injections; Isoxazoles; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia

2014
Population pharmacokinetic modeling and simulation to guide dose selection for RBP-7000, a new sustained-release formulation of risperidone.
    Journal of clinical pharmacology, 2015, Volume: 55, Issue:1

    Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Female; Humans; Isoxazoles; Male; Middle Aged; Models, Biological; Paliperidone Palmitate; Palmitates; Pyrimidines; Risperidone

2015
Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophrenia.
    Clinical schizophrenia & related psychoses, 2015, Volume: 8, Issue:4

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dizziness; Female; Humans; Isoxazoles; Male; Olanzapine; Piperazines; Piperidines; Quinolones; Risperidone; Schizophrenia; Treatment Outcome

2015
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial.
    BMC psychiatry, 2016, 05-29, Volume: 16

    Topics: Adult; Antipsychotic Agents; Cognition; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Treatment Outcome

2016

Other Studies

275 other study(ies) available for isoxazoles and risperidone

ArticleYear
Determination of risperidone and 9-hydroxyrisperidone in plasma, urine and animal tissues by high-performance liquid chromatography.
    Journal of chromatography, 1992, Dec-02, Volume: 583, Issue:2

    Topics: Animals; Calibration; Chromatography, High Pressure Liquid; Isoxazoles; Paliperidone Palmitate; Piperidines; Pyrimidines; Quality Control; Reproducibility of Results; Risperidone; Spectrophotometry, Ultraviolet

1992
Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:1

    Topics: Animals; Antiemetics; Antipsychotic Agents; Apomorphine; Behavior, Animal; Body Temperature; Dogs; Dopamine Agents; Dopamine Antagonists; Eating; Female; Haloperidol; Isoxazoles; Lethal Dose 50; Locomotion; Male; Mice; Motor Activity; Muscles; Neurotransmitter Agents; Piperidines; Posture; Pyrimidinones; Rats; Rats, Inbred Strains; Risperidone; Ritanserin; Serotonin; Serotonin Antagonists; Synaptic Transmission

1992
Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:1

    Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Isoxazoles; Male; Motor Activity; Piperidines; Pyrimidinones; Rats; Rats, Inbred Strains; Risperidone

1992
In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
    Molecular pharmacology, 1992, Volume: 41, Issue:3

    Topics: Animals; Antipsychotic Agents; Biogenic Monoamines; Brain; Female; Haloperidol; In Vitro Techniques; Isoxazoles; Male; Neurotransmitter Agents; Piperidines; Pyrimidinones; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Risperidone; Spiperone; Tissue Distribution

1992
Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:2

    Topics: Animals; Antipsychotic Agents; Cells, Cultured; Haloperidol; Isoxazoles; Ketanserin; Male; Piperidines; Pituitary Gland; Prolactin; Rats; Rats, Inbred Strains; Risperidone; Spiro Compounds; Stimulation, Chemical

1992
Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.
    Pharmacopsychiatry, 1992, Volume: 25, Issue:5

    Topics: Adult; Aged; Antipsychotic Agents; Depressive Disorder; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Syndrome

1992
Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:3

    Topics: Animals; Antipsychotic Agents; Apomorphine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Injections, Intravenous; Isoxazoles; Male; Piperidines; Rats; Rats, Inbred Strains; Risperidone; Ritanserin; Seizures; Serotonin; Serotonin Antagonists; Synaptic Transmission; Tryptamines

1990
[Study by the intracerebral microdialysis method of the effects of atypical neuroleptics and anxiolytics on striatal release and metabolism of dopamine in awake rats].
    Biulleten' eksperimental'noi biologii i meditsiny, 1991, Volume: 111, Issue:5

    Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Brain Chemistry; Buspirone; Corpus Striatum; Dialysis; Dopamine; In Vitro Techniques; Isoxazoles; Male; Methoxydimethyltryptamines; Piperidines; Rats; Rats, Inbred Strains; Risperidone; Ritanserin; Sulpiride; Wakefulness

1991
Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
    Pharmacopsychiatry, 1991, Volume: 24, Issue:6

    Topics: Acute Disease; Adult; Antipsychotic Agents; Chronic Disease; Female; Humans; Isoxazoles; Male; Middle Aged; Pilot Projects; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia

1991
Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 244, Issue:2

    Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Conditioning, Psychological; Dogs; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Isoxazoles; Male; Motor Activity; Oxazoles; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Risperidone; Serotonin Antagonists

1988
Biochemical profile of risperidone, a new antipsychotic.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 247, Issue:2

    Topics: Animals; Antipsychotic Agents; Blood Platelets; Cerebral Cortex; Dopamine; Ergolines; Female; Haloperidol; Isoxazoles; Models, Molecular; Norepinephrine; Oxazoles; Phosphatidic Acids; Piperidines; Quinpirole; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Ritanserin; X-Ray Diffraction

1988
Differential effects of the new antipsychotic risperidone on large and small motor movements in rats: a comparison with haloperidol.
    Psychopharmacology, 1988, Volume: 95, Issue:4

    Topics: Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Motor Activity; Oxazoles; Piperidines; Rats; Rats, Inbred Strains; Risperidone

1988
Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats.
    Psychopharmacology, 1989, Volume: 97, Issue:2

    Topics: Animals; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Stimulus; Isoxazoles; Lysergic Acid Diethylamide; Male; Oxazoles; Piperidines; Rats; Rats, Inbred Strains; Risperidone

1989
Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients.
    Psychopharmacology, 1989, Volume: 99, Issue:4

    Topics: Adult; Aged; Antipsychotic Agents; Blood Pressure; Electrocardiography; Female; Hormones; Humans; Isoxazoles; Male; Middle Aged; Oxazoles; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone

1989
Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography.
    Brain research, 1989, Oct-23, Volume: 500, Issue:1-2

    Topics: Animals; Brain; Dopamine Antagonists; Isoxazoles; Male; Oxazoles; Piperidines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Ritanserin; Serotonin Antagonists

1989
Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat.
    Neuropharmacology, 1989, Volume: 28, Issue:12

    Topics: Animals; Antipsychotic Agents; Isoxazoles; Male; Oxazoles; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Sleep; Wakefulness

1989
Adverse reaction reporting and new antipsychotics.
    Lancet (London, England), 1993, Dec-11, Volume: 342, Issue:8885

    Topics: Agranulocytosis; Anemia, Aplastic; Antipsychotic Agents; Clozapine; Drug Monitoring; Humans; Isoxazoles; Neutropenia; Piperidines; Remoxipride; Risperidone; Schizophrenia

1993
Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone.
    The British journal of psychiatry : the journal of mental science, 1993, Volume: 163

    Topics: Adult; Antipsychotic Agents; Benzamides; Brain; Brain Mapping; Contrast Media; Dopamine D2 Receptor Antagonists; Humans; Iodine Radioisotopes; Isoxazoles; Male; Piperidines; Psychiatric Status Rating Scales; Pyrrolidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon

1993
Risperidone and remoxipride for schizophrenia.
    Drug and therapeutics bulletin, 1993, Dec-20, Volume: 31, Issue:26

    Topics: Antipsychotic Agents; Female; Humans; Isoxazoles; Piperidines; Remoxipride; Risperidone; Schizophrenia

1993
5-HT2 receptor antagonists do not reduce ethanol preference in Sardinian alcohol-preferring (sP) rats.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 46, Issue:4

    Topics: Alcohol Drinking; Animals; Antipsychotic Agents; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Risperidone; Ritanserin; Serotonin Antagonists

1993
Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
    Brain research, 1993, Dec-24, Volume: 631, Issue:2

    Topics: Animals; Antipsychotic Agents; Apomorphine; Autoradiography; Behavior, Animal; Clozapine; Guinea Pigs; Haloperidol; In Vitro Techniques; Iodine Radioisotopes; Isoxazoles; Male; Mescaline; Piperidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Neurotransmitter; Receptors, Serotonin; Risperidone; Stereotyped Behavior

1993
Risperidone for chronic schizophrenia.
    The Medical letter on drugs and therapeutics, 1994, Apr-15, Volume: 36, Issue:920

    Topics: Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1994
Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
    Arzneimittel-Forschung, 1994, Volume: 44, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Behavior, Animal; Body Temperature; Clozapine; Dibenzothiepins; Exploratory Behavior; Haloperidol; Isoxazoles; Male; Mice; Motor Activity; Piperazines; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Serotonin Receptor Agonists

1994
Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs.
    Neuroscience, 1994, Volume: 58, Issue:3

    Topics: Action Potentials; Animals; Antipsychotic Agents; Bicuculline; Cerebral Cortex; Chlorpromazine; Clozapine; Electrophysiology; gamma-Aminobutyric Acid; Haloperidol; In Vitro Techniques; Interneurons; Isoxazoles; Male; Membrane Potentials; Piperidines; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin Antagonists

1994
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
    Lancet (London, England), 1994, May-28, Volume: 343, Issue:8909

    Topics: Aged; Antipsychotic Agents; Hallucinations; Humans; Isoxazoles; Levodopa; Parkinson Disease; Piperidines; Risperidone

1994
Risperidone.
    The American journal of psychiatry, 1994, Volume: 151, Issue:6

    Topics: Adult; Clinical Trials as Topic; Humans; Isoxazoles; Multicenter Studies as Topic; Piperidines; Placebos; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome

1994
Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
    Arzneimittel-Forschung, 1994, Volume: 44, Issue:3

    Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Butyrophenones; Dogs; Dopamine D2 Receptor Antagonists; Haloperidol; Humans; In Vitro Techniques; Isoxazoles; Lysergic Acid Diethylamide; Motor Activity; Neostriatum; Oxygen Consumption; Piperidines; Rats; Risperidone; Schizophrenia; Serotonin Antagonists; Species Specificity; Tryptamines

1994
In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 47, Issue:3

    Topics: Animals; Antipsychotic Agents; Benzamides; Brain; Cerebellum; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; In Vitro Techniques; Isoxazoles; Ketanserin; Ligands; Male; Neostriatum; Piperidines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone

1994
Schizophrenia.
    The New England journal of medicine, 1994, Jul-28, Volume: 331, Issue:4

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1994
Risperidone for schizophrenia.
    BMJ (Clinical research ed.), 1994, May-21, Volume: 308, Issue:6940

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1994
Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1994, Volume: 39, Issue:3

    Topics: Adult; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Dystonia; Humans; Isoxazoles; Male; Neurologic Examination; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome

1994
New antipsychotic agent, risperidone, introduced.
    American journal of hospital pharmacy, 1994, May-01, Volume: 51, Issue:9

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychotic Disorders; Risperidone

1994
Risperidone-induced priapism.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1994, Volume: 39, Issue:5

    Topics: Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Humans; Isoxazoles; Lithium Carbonate; Lorazepam; Male; Middle Aged; Piperidines; Priapism; Risperidone; Schizophrenia, Paranoid

1994
Risperidone: a novel antipsychotic medication.
    Hospital & community psychiatry, 1994, Volume: 45, Issue:5

    Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
New drug offers hope for people with schizophrenia.
    Journal of psychosocial nursing and mental health services, 1994, Volume: 32, Issue:5

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
The effect of risperidone and ritanserin on human IgG and IgM synthesis in vitro.
    Physiological research, 1994, Volume: 43, Issue:1

    Topics: Antipsychotic Agents; B-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Immunoglobulin M; In Vitro Techniques; Isoxazoles; Monocytes; Piperidines; Pokeweed Mitogens; Risperidone; Ritanserin; Schizophrenia

1994
Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder.
    Lancet (London, England), 1994, Aug-20, Volume: 344, Issue:8921

    Topics: Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Humans; Isoxazoles; Piperidines; Risperidone

1994
Response to clozapine as a predictor of risperidone response in schizophrenia.
    The American journal of psychiatry, 1994, Volume: 151, Issue:9

    Topics: Adult; Antipsychotic Agents; Clozapine; Female; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Risperidone; Schizophrenia; Treatment Outcome

1994
The pharmacokinetics of risperidone in humans: a summary.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Aged; Animals; Antipsychotic Agents; Biotransformation; Dogs; Half-Life; Humans; Isoxazoles; Liver Cirrhosis; Male; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Reference Values; Renal Insufficiency; Risperidone; Schizophrenia

1994
Risperidone: new horizons for the schizophrenic patient. 9th World Congress of Psychiatry of the World Psychiatric Association, Rio de Janeiro, June 1993.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1994
Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
    The Journal of clinical psychiatry, 1994, Volume: 55 Suppl

    Topics: Animals; Antipsychotic Agents; Brain; Clone Cells; Clozapine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Haloperidol; Humans; Isoxazoles; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Serotonin Antagonists

1994
Risperidone in Parkinson's disease.
    Lancet (London, England), 1994, Sep-03, Volume: 344, Issue:8923

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Parkinson Disease; Piperidines; Psychotic Disorders; Risperidone

1994
Risperidone in HIV-related manic psychosis.
    Lancet (London, England), 1994, Oct-08, Volume: 344, Issue:8928

    Topics: AIDS Dementia Complex; Antipsychotic Agents; Bipolar Disorder; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone

1994
Risperidone-induced neuroleptic malignant syndrome.
    Lancet (London, England), 1994, Oct-29, Volume: 344, Issue:8931

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; Piperidines; Risperidone

1994
Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia.
    The American journal of psychiatry, 1994, Volume: 151, Issue:11

    Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Fluvoxamine; Humans; Isoxazoles; Male; Obsessive-Compulsive Disorder; Piperidines; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin

1994
FDA approved new drug bulletin: risperidone (risperdal).
    RN, 1994, Volume: 57, Issue:6

    Topics: Adult; Antipsychotic Agents; Child; Drug Interactions; Female; Humans; Isoxazoles; Patient Education as Topic; Piperidines; Pregnancy; Risperidone

1994
Risperidone in adolescents.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1994, Volume: 33, Issue:8

    Topics: Adolescent; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hospitalization; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
Risperidone for Tourette's syndrome.
    Lancet (London, England), 1994, Dec-03, Volume: 344, Issue:8936

    Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Piperidines; Risperidone; Severity of Illness Index; Tourette Syndrome

1994
Risperidone treatment for severe negative symptoms.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1994, Volume: 39, Issue:6

    Topics: Adult; Antipsychotic Agents; Clonazepam; Depressive Disorder; Drug Therapy, Combination; Humans; Isoxazoles; Male; Patient Readmission; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
Risperidone in the treatment of pervasive developmental disorder.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1994, Volume: 39, Issue:7

    Topics: Adolescent; Adult; Antipsychotic Agents; Autistic Disorder; Child; Child Development Disorders, Pervasive; Follow-Up Studies; Humans; Intellectual Disability; Isoxazoles; Male; Neuropsychological Tests; Piperidines; Risperidone; Serotonin; Stereotyped Behavior

1994
Risperidone's cost.
    Hospital & community psychiatry, 1994, Volume: 45, Issue:9

    Topics: Antipsychotic Agents; Delivery of Health Care; Health Services Accessibility; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1994
Risperidone-induced neuroleptic malignant syndrome in young patient.
    Lancet (London, England), 1994, Dec-17, Volume: 344, Issue:8938

    Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; Piperidines; Risperidone

1994
Cortical response to exogenous visual stimulation during visual hallucinations.
    Lancet (London, England), 1995, Jan-07, Volume: 345, Issue:8941

    Topics: Aged; Antipsychotic Agents; Dementia; Evoked Potentials, Visual; Hallucinations; Humans; Isoxazoles; Magnetic Resonance Imaging; Male; Piperidines; Risperidone; Visual Cortex

1995
High-dose antipsychotic medication.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 165, Issue:4

    Topics: Adult; Ambulatory Care; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
Risperidone and obsessive-compulsive symptoms.
    Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:5

    Topics: Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Isoxazoles; Lithium Carbonate; Male; Middle Aged; Neurologic Examination; Obsessive-Compulsive Disorder; Pimozide; Piperidines; Recurrence; Risperidone

1994
Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone.
    European journal of pharmacology, 1994, Oct-13, Volume: 264, Issue:1

    Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Fluorobenzenes; Isoxazoles; Male; Motor Activity; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Risperidone; Serotonin Antagonists

1994
Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.
    Psychopharmacology, 1993, Volume: 112, Issue:1 Suppl

    Topics: Animals; Antipsychotic Agents; Autoradiography; Clozapine; Haloperidol; In Vitro Techniques; Isoxazoles; Male; Piperidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Neurotransmitter; Receptors, Serotonin; Risperidone

1993
Risperidone.
    Hospital & community psychiatry, 1994, Volume: 45, Issue:11

    Topics: Adolescent; Adult; Antipsychotic Agents; Community Mental Health Services; Humans; Isoxazoles; Mental Disorders; Piperidines; Risperidone

1994
Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:6

    Topics: Adult; Antipsychotic Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isoxazoles; Male; Middle Aged; Neurologic Examination; Pilot Projects; Piperidines; Risperidone; Serotonin Antagonists; Tourette Syndrome

1994
Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat.
    Psychopharmacology, 1994, Volume: 114, Issue:1

    Topics: Animals; Antiemetics; Antipsychotic Agents; Apomorphine; Brain; Dogs; Half-Life; Injections, Subcutaneous; Isoxazoles; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Organ Size; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Rats, Wistar; Receptors, Neurotransmitter; Risperidone; Spectrophotometry, Ultraviolet; Tryptamines

1994
Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:2

    Topics: Animals; Antipsychotic Agents; Clozapine; Conditioning, Operant; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Rats, Wistar; Remoxipride; Risperidone; Serotonin Antagonists; Sulpiride

1995
Agitated behavior relieved following treatment of cervical dystonia in dementia.
    Neurology, 1995, Volume: 45, Issue:2

    Topics: Alzheimer Disease; Botulinum Toxins; Chlorpromazine; Dystonia; Female; Humans; Isoxazoles; Middle Aged; Neck Muscles; Phenytoin; Piperidines; Risperidone; Valproic Acid

1995
Plasma protein binding of risperidone and its distribution in blood.
    Psychopharmacology, 1994, Volume: 114, Issue:4

    Topics: Adult; Aged; Animals; Antipsychotic Agents; Blood Cells; Blood Proteins; Dogs; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Isoxazoles; Kidney Diseases; Liver Diseases; Male; Middle Aged; Orosomucoid; Paliperidone Palmitate; Piperidines; Protein Binding; Pyrimidines; Rats; Rats, Wistar; Risperidone; Serum Albumin

1994
Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
    Japanese journal of pharmacology, 1994, Volume: 66, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Frontal Lobe; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Isoxazoles; Locomotion; Male; Phencyclidine; Piperidines; Random Allocation; Rats; Rats, Wistar; Risperidone; Ritanserin; Schizophrenia; Serotonin; Stereotyped Behavior

1994
Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine.
    Life sciences, 1995, Volume: 56, Issue:7

    Topics: Animals; Antipsychotic Agents; Dizocilpine Maleate; Drug Tolerance; Haloperidol; Isoxazoles; Male; Methamphetamine; Motor Activity; Phencyclidine; Piperidines; Rats; Rats, Wistar; Receptors, Phencyclidine; Receptors, Serotonin; Risperidone; Ritanserin

1995
Novel neuroleptics in schizophrenia: theory and clinical relevance.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1994, Volume: 39, Issue:9 Suppl 2

    Topics: Antipsychotic Agents; Brain; Clozapine; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
Re: Hypomania associated with risperidone.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1995, Volume: 40, Issue:1

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Chronic Disease; Female; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia, Paranoid

1995
Schizophrenia and severe tardive dyskinesia responsive to risperidone.
    Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:6

    Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Isoxazoles; Neurologic Examination; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology

1994
Addressing emerging social needs of patients treated with new neuroleptics.
    Journal of psychosocial nursing and mental health services, 1994, Volume: 32, Issue:11

    Topics: Adult; Antipsychotic Agents; Clozapine; Female; Humans; Isoxazoles; Male; Middle Aged; Nursing Assessment; Piperidines; Psychiatric Nursing; Risperidone; Schizophrenia; Socialization

1994
Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:1 Suppl 1

    Topics: Adult; Antipsychotic Agents; Binding Sites; Brain; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Tomography, Emission-Computed

1995
Risperidone in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 58, Issue:4

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Parkinson Disease; Piperidines; Risperidone

1995
Recent developments in antipsychotic therapy. Introduction.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Feb-01, Volume: 52, Issue:3 Suppl 1

    Topics: Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1995
Risperidone in childhood schizophrenia.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1995, Volume: 34, Issue:5

    Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Drug Therapy, Combination; Humans; Isoxazoles; Male; Methylphenidate; Piperidines; Risperidone; Schizophrenia; Treatment Outcome

1995
Effects of concomitant risperidone and lithium treatment.
    The American journal of psychiatry, 1995, Volume: 152, Issue:7

    Topics: Antipsychotic Agents; Confusion; Creatine Kinase; Drug Therapy, Combination; Fever; Humans; Isoxazoles; Lithium Carbonate; Neuroleptic Malignant Syndrome; Piperidines; Risperidone; Schizophrenia

1995
Behavioral stimulation associated with risperidone initiation.
    The American journal of psychiatry, 1995, Volume: 152, Issue:7

    Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Anxiety; Benzodiazepines; Confusion; Female; Humans; Isoxazoles; Middle Aged; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome

1995
Prolonged erection associated with risperidone treatment.
    The American journal of psychiatry, 1995, Volume: 152, Issue:7

    Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Piperidines; Priapism; Psychotic Disorders; Risperidone

1995
Risperidone treatment for a Tourette's disorder patient with comorbid obsessive-compulsive disorder.
    The American journal of psychiatry, 1995, Volume: 152, Issue:7

    Topics: Adult; Antipsychotic Agents; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Isoxazoles; Male; Obsessive-Compulsive Disorder; Piperidines; Risperidone; Tourette Syndrome; Treatment Outcome

1995
Switching patients from clozapine to risperidone therapy.
    The American journal of psychiatry, 1995, Volume: 152, Issue:7

    Topics: Antipsychotic Agents; Clonazepam; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoxazoles; Lorazepam; Piperidines; Risperidone; Schizophrenia; Substance Withdrawal Syndrome

1995
Risperidone-induced prolactin elevations in premenopausal women with schizophrenia.
    The American journal of psychiatry, 1995, Volume: 152, Issue:7

    Topics: Antipsychotic Agents; Female; Humans; Hyperprolactinemia; Isoxazoles; Piperidines; Premenopause; Prolactin; Risperidone; Schizophrenia

1995
Prescribing risperidone.
    Psychiatric services (Washington, D.C.), 1995, Volume: 46, Issue:3

    Topics: Antipsychotic Agents; Cost-Benefit Analysis; Drug Prescriptions; Financing, Government; Health Care Rationing; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Virginia

1995
Risperidone for psychotic and behavioural symptoms in Lewy body dementia.
    Lancet (London, England), 1995, Jul-15, Volume: 346, Issue:8968

    Topics: Aged; Antipsychotic Agents; Dementia; Female; Humans; Isoxazoles; Male; Piperidines; Risperidone

1995
Risperidone for the treatment of schizophrenia: does it have a niche?
    South Dakota journal of medicine, 1995, Volume: 48, Issue:5

    Topics: Dopamine Antagonists; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology

1995
Reversible neutropenia during a cold: possible involvement of risperidone? A case report.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1995, Volume: 5, Issue:1

    Topics: Adult; Antipsychotic Agents; Cold Temperature; Female; Humans; Influenza, Human; Isoxazoles; Neutropenia; Piperidines; Risperidone; Schizophrenia

1995
Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 1995, Volume: 5, Issue:1

    Topics: Adult; Antipsychotic Agents; Autopsy; Autoradiography; Binding Sites; Brain; Clozapine; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone

1995
Risperidone in Gilles de la Tourette syndrome.
    Neurology, 1995, Volume: 45, Issue:7

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Tourette Syndrome

1995
Risperidone augmentation of clozapine.
    Pharmacopsychiatry, 1995, Volume: 28, Issue:2

    Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone; Schizophrenia, Paranoid; Schizophrenic Psychology

1995
Risperidone for treatment-refractory schizophrenia.
    The American journal of psychiatry, 1995, Volume: 152, Issue:8

    Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Piperidines; Risperidone; Schizophrenia; Treatment Outcome

1995
Two cases of risperidone-induced neuroleptic malignant syndrome.
    The American journal of psychiatry, 1995, Volume: 152, Issue:8

    Topics: Adult; Antipsychotic Agents; Female; Humans; Isoxazoles; Neuroleptic Malignant Syndrome; Piperidines; Primidone; Psychotic Disorders; Risperidone; Tremor

1995
Two cases of risperidone-induced neuroleptic malignant syndrome.
    The American journal of psychiatry, 1995, Volume: 152, Issue:8

    Topics: Aged; Antipsychotic Agents; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; Piperidines; Risperidone; Schizophrenia, Paranoid

1995
Use of risperidone with a patient sensitive to conventional neuroleptic drugs.
    The American journal of psychiatry, 1995, Volume: 152, Issue:8

    Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Isoxazoles; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperidines; Risperidone; Treatment Outcome

1995
Risperidone for treating dementia-associated aggression.
    The American journal of psychiatry, 1995, Volume: 152, Issue:8

    Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Dementia; Dementia, Vascular; Female; Humans; Isoxazoles; Male; Piperidines; Psychotropic Drugs; Risperidone; Treatment Outcome

1995
Clinical implications of clozapine discontinuation: report of an NIMH workshop.
    Schizophrenia bulletin, 1995, Volume: 21, Issue:2

    Topics: Antipsychotic Agents; Clozapine; Drug Administration Schedule; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; United States; United States Food and Drug Administration

1995
Unexpected dystonia while changing from clozapine to risperidone.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:3

    Topics: Adult; Antipsychotic Agents; Clozapine; Dystonia; Humans; Isoxazoles; Male; Piperidines; Risperidone; Schizophrenia

1995
Concomitant use of thioridazine with risperidone.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, May-01, Volume: 52, Issue:9

    Topics: Antipsychotic Agents; Drug Therapy, Combination; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Thioridazine

1995
The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.
    Life sciences, 1995, Volume: 57, Issue:10

    Topics: Adult; Akathisia, Drug-Induced; Basal Ganglia Diseases; Humans; Isoxazoles; Male; Piperidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed

1995
Clinical experience with risperidone.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1995, Volume: 34, Issue:7

    Topics: Adolescent; Aggression; Antipsychotic Agents; Bipolar Disorder; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isoxazoles; Lithium; Male; Piperidines; Risperidone

1995
Is risperidone a substitute for clozapine for patients who do not respond to neuroleptics?
    The American journal of psychiatry, 1995, Volume: 152, Issue:9

    Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Piperidines; Recurrence; Risperidone; Schizophrenia; Schizophrenia, Paranoid

1995
Pharmacokinetic interaction between risperidone and clozapine.
    The American journal of psychiatry, 1995, Volume: 152, Issue:9

    Topics: Adult; Antipsychotic Agents; Clozapine; Drug Interactions; Drug Therapy, Combination; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone

1995
Neuroleptic sensitivity to risperidone in Lewy body dementia.
    Lancet (London, England), 1995, Sep-09, Volume: 346, Issue:8976

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Dementia; Female; Humans; Isoxazoles; Lewy Bodies; Male; Middle Aged; Parkinson Disease; Piperidines; Risperidone

1995
Olanzapine, an atypical antipsychotic, increases rates of punished responding in pigeons.
    Psychopharmacology, 1995, Volume: 119, Issue:2

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Chlordiazepoxide; Clozapine; Columbidae; Conditioning, Operant; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Olanzapine; Piperidines; Pirenzepine; Punishment; Risperidone

1995
Risperidone treatment of refractory acute mania.
    The Journal of clinical psychiatry, 1995, Volume: 56, Issue:9

    Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Isoxazoles; Male; Piperidines; Risperidone; Treatment Outcome

1995
The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 274, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Basal Ganglia Diseases; Behavior, Animal; Clozapine; Dopamine Antagonists; Haloperidol; Isoxazoles; Male; Mice; Piperidines; Radioligand Assay; Rats; Rats, Wistar; Risperidone; Saimiri; Serotonin Antagonists

1995
Suppression of alcohol preference in rats induced by risperidone, a serotonin 5-HT2 and dopamine D2 receptor antagonist.
    Brain research bulletin, 1993, Volume: 31, Issue:5

    Topics: Alcohol Drinking; Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Rats, Wistar; Risperidone; Serotonin Antagonists

1993
Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:2

    Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Haloperidol; Isoxazoles; Male; Piperidines; Quinolines; Rats; Rats, Wistar; Receptors, Dopamine D1; Risperidone; Serotonin Antagonists

1993
[Clinical evaluation of risperidone].
    Ceskoslovenska psychiatrie, 1993, Volume: 89, Issue:1

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychotic Disorders; Risperidone

1993
Neuroleptics and the immune system.
    Ceskoslovenska psychiatrie, 1993, Volume: 89, Issue:1

    Topics: Adult; Antipsychotic Agents; Female; Humans; Immunity; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone

1993
Effects of atypical antipsychotic agents on social behavior in rodents.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 45, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Catalepsy; Chlorpromazine; Clozapine; Diazepam; Haloperidol; Isoxazoles; Male; Mice; Mice, Inbred Strains; Piperidines; Raclopride; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Social Behavior

1993
Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection.
    Journal of chromatography, 1993, May-05, Volume: 614, Issue:2

    Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Isoxazoles; Paliperidone Palmitate; Piperidines; Pyrimidines; Regression Analysis; Risperidone

1993
[Effects of risperidone on catalepsy and cerebral dopamine, serotonin and GABA metabolism in the rat: comparison with haloperidol].
    Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology, 1993, Volume: 13, Issue:1

    Topics: Animals; Antipsychotic Agents; Brain; Catalepsy; Dopamine; gamma-Aminobutyric Acid; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Rats, Wistar; Risperidone; Serotonin

1993
[A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
    [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1993, Volume: 68, Issue:4

    Topics: Animals; Antipsychotic Agents; Autoradiography; Brain; Chlorpromazine; Clozapine; Dibenzothiepins; Flupenthixol; Haloperidol; In Vitro Techniques; Isoxazoles; Male; Piperidines; Pyrimidinones; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Serotonin; Risperidone

1993
Clozapine in the management of schizophrenia. Risperidone is less toxic but equally effective.
    BMJ (Clinical research ed.), 1993, Jul-17, Volume: 307, Issue:6897

    Topics: Antipsychotic Agents; Clozapine; Drug Costs; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia

1993
Determination of risperidone in plasma by high-performance liquid chromatography with electrochemical detection: application to therapeutic drug monitoring in schizophrenic patients.
    Journal of pharmaceutical sciences, 1993, Volume: 82, Issue:5

    Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Isoxazoles; Piperidines; Remoxipride; Risperidone; Schizophrenia

1993
Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics.
    European journal of pharmacology, 1993, Jun-24, Volume: 237, Issue:2-3

    Topics: Animals; Antipsychotic Agents; Benzamides; Brain; Clozapine; Corpus Striatum; Dopamine D2 Receptor Antagonists; In Vitro Techniques; Isoxazoles; Male; Olfactory Pathways; Piperidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Risperidone; Spiperone; Thioridazine

1993
Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.
    Clinical pharmacology and therapeutics, 1993, Volume: 54, Issue:3

    Topics: Adult; Antipsychotic Agents; Biological Availability; Humans; Isoxazoles; Male; Models, Biological; Piperidines; Prolactin; Random Allocation; Reference Values; Risperidone

1993
Pharmacological effects of zotepine and other antipsychotics on the central 5-HT2 receptors.
    Pharmacopsychiatry, 1993, Volume: 26, Issue:2

    Topics: Animals; Antipsychotic Agents; Clozapine; Dibenzothiepins; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Risperidone

1993
Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors.
    European journal of pharmacology, 1993, Jul-20, Volume: 238, Issue:2-3

    Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Binding Sites; Dioxanes; Hippocampus; In Vitro Techniques; Isoxazoles; Male; Phentolamine; Piperazines; Piperidines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Risperidone; Spleen

1993
Overdose of risperidone.
    Annals of emergency medicine, 1993, Volume: 22, Issue:12

    Topics: Adult; Antipsychotic Agents; Electrocardiography; Humans; Isoxazoles; Male; Piperidines; Poisoning; Risperidone; Suicide, Attempted

1993
Therapeutic drug monitoring of risperidone and 9-hydroxyrisperidone in serum with solid-phase extraction and high-performance liquid chromatography.
    Therapeutic drug monitoring, 1997, Volume: 19, Issue:3

    Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone

1997
Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in serum from patients comedicated with other psychotropic drugs.
    Journal of chromatography. B, Biomedical sciences and applications, 1997, Sep-26, Volume: 698, Issue:1-2

    Topics: Antipsychotic Agents; Artifacts; Chromatography, High Pressure Liquid; Haloperidol; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Spectrophotometry, Ultraviolet

1997
Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat.
    Psychopharmacology, 1998, Volume: 139, Issue:4

    Topics: Animals; Antipsychotic Agents; Brain; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Tissue Distribution

1998
Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4.
    Naunyn-Schmiedeberg's archives of pharmacology, 1999, Volume: 359, Issue:2

    Topics: Animals; Antipsychotic Agents; Biotransformation; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA, Complementary; Humans; Isoenzymes; Isoxazoles; Microsomes, Liver; Mixed Function Oxygenases; Paliperidone Palmitate; Pyrimidines; Rats; Recombinant Proteins; Risperidone

1999
Effect of venlafaxine on the pharmacokinetics of risperidone.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:3

    Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Area Under Curve; Cyclohexanols; Desvenlafaxine Succinate; Exploratory Behavior; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Paliperidone Palmitate; Psychomotor Performance; Pyrimidines; Risperidone; Venlafaxine Hydrochloride

1999
Pharmacokinetic-pharmacodynamic modeling of risperidone effects on electroencephalography in healthy volunteers.
    Psychopharmacology, 1999, Volume: 144, Issue:3

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Electroencephalography; Humans; Isoxazoles; Male; Models, Biological; Paliperidone Palmitate; Pyrimidines; Risperidone

1999
A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A.
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:7

    Topics: Adolescent; Adult; Antipsychotic Agents; Aryl Hydrocarbon Hydroxylases; Case-Control Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Isoxazoles; Male; Mental Disorders; Middle Aged; Oxidoreductases, N-Demethylating; Paliperidone Palmitate; Pilot Projects; Pyrimidines; Risperidone

1999
Simultaneous determination of paroxetine, risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with coulometric detection.
    Pharmacology, 2000, Volume: 60, Issue:1

    Topics: Chromatography, High Pressure Liquid; Colorimetry; Drug Monitoring; Humans; Isoxazoles; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Spectrophotometry, Ultraviolet

2000
Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding.
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:2

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Breast Feeding; Female; Humans; Infant, Newborn; Isoxazoles; Milk, Human; Paliperidone Palmitate; Pregnancy; Pyrimidines; Risperidone

2000
Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.
    British journal of clinical pharmacology, 2000, Volume: 49 Suppl 1

    Topics: Antipsychotic Agents; Biotransformation; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Isoxazoles; Liver; Microsomes, Liver; Paliperidone Palmitate; Piperazines; Pyrimidines; Risperidone; Sulfones; Sulfoxides; Thiazoles

2000
Simultaneous determination of risperidone and 9-hydroxyrisperidone in plasma by liquid chromatography/electrospray tandem mass spectrometry.
    Journal of mass spectrometry : JMS, 2000, Volume: 35, Issue:6

    Topics: Animals; Antipsychotic Agents; Chromatography, Liquid; Humans; Isoxazoles; Mass Spectrometry; Paliperidone Palmitate; Pyrimidines; Rats; Risperidone; Schizophrenia; Sensitivity and Specificity

2000
Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate.
    Therapeutic drug monitoring, 2000, Volume: 22, Issue:4

    Topics: Adult; Antipsychotic Agents; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Mixed Function Oxygenases; Paliperidone Palmitate; Pyrimidines; Risperidone; Valproic Acid

2000
Risperidone metabolism and the impact of being a cytochrome P450 2D6 ultrarapid metabolizer.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:8

    Topics: Adolescent; Adult; Cytochrome P-450 CYP2D6; Drug Monitoring; Genotype; Humans; Isoxazoles; Male; Paliperidone Palmitate; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pyrimidines; Risperidone

2000
Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reversed-phase liquid chromatography with ultraviolet detection.
    Journal of chromatography. B, Biomedical sciences and applications, 2000, Sep-15, Volume: 746, Issue:2

    Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Sensitivity and Specificity; Spectrophotometry, Ultraviolet

2000
Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine.
    Therapeutic drug monitoring, 2001, Volume: 23, Issue:3

    Topics: Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Paroxetine; Pyrimidines; Risperidone; Selective Serotonin Reuptake Inhibitors

2001
Possible relationship between combined plasma concentrations of risperidone plus 9-hydroxyrisperidone and extrapyramidal symptoms. Preliminary study.
    Neuropsychobiology, 2001, Volume: 44, Issue:3

    Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia

2001
Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats.
    Psychopharmacology, 2002, Volume: 159, Issue:4

    Topics: Administration, Oral; Animals; Antipsychotic Agents; Brain; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin Antagonists; Tissue Distribution

2002
In vivo and in vitro myocardial binding of risperidone and 9-hydroxyrisperidone.
    Toxicology and applied pharmacology, 2002, Apr-15, Volume: 180, Issue:2

    Topics: Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Guinea Pigs; Isoxazoles; Myocardium; Paliperidone Palmitate; Pyrimidines; Risperidone

2002
Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in plasma after overdose.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2002, Jun-05, Volume: 772, Issue:2

    Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Overdose; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Sensitivity and Specificity

2002
Risperidone and 9-hydroxyrisperidone concentrations are not dependent on age or creatinine clearance among elderly subjects.
    Journal of geriatric psychiatry and neurology, 2002,Summer, Volume: 15, Issue:2

    Topics: Age Factors; Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Creatinine; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Radioimmunoassay; Risperidone

2002
Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy.
    Synapse (New York, N.Y.), 2002, Volume: 46, Issue:1

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Dopamine Antagonists; Humans; Isoxazoles; Models, Biological; Paliperidone Palmitate; Pyrimidines; Receptors, Dopamine D2; Risperidone

2002
A colloidal graphite-coated emitter for sheathless capillary electrophoresis/nanoelectrospray ionization mass spectrometry.
    Analytical chemistry, 2002, Oct-15, Volume: 74, Issue:20

    Topics: Colloids; Electrophoresis, Capillary; Graphite; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Spectrometry, Mass, Electrospray Ionization

2002
Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003, Jan-05, Volume: 783, Issue:1

    Topics: Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Drug Interactions; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone

2003
Validated method for the determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography-tandem mass spectrometry.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003, Jan-15, Volume: 783, Issue:2

    Topics: Antipsychotic Agents; Chromatography, Liquid; Humans; Isoxazoles; Mass Spectrometry; Paliperidone Palmitate; Pyrimidines; Risperidone

2003
Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients.
    Pharmacopsychiatry, 2002, Volume: 35, Issue:6

    Topics: Adult; Aged; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Genotype; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Phenotype; Pyrimidines; Risperidone; Schizophrenia; White People

2002
[Determination of risperidone and 9-hydroxyrisperidone in plasma by high performance liquid chromatography].
    Se pu = Chinese journal of chromatography, 1999, Volume: 17, Issue:4

    Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Serotonin Antagonists

1999
alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
    European journal of pharmacology, 2003, Feb-21, Volume: 462, Issue:1-3

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brimonidine Tartrate; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Cyclic AMP; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Humans; Isoxazoles; Norepinephrine; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Quinolones; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Risperidone; Thiazoles; Transfection; Yohimbine

2003
Effects of CYP2D6 genotypes on plasma concentrations of risperidone and enantiomers of 9-hydroxyrisperidone in Japanese patients with schizophrenia.
    Journal of clinical pharmacology, 2003, Volume: 43, Issue:2

    Topics: Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Genotype; Half-Life; Humans; Hydroxylation; Isoxazoles; Japan; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Stereoisomerism

2003
Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia.
    Therapeutic drug monitoring, 2003, Volume: 25, Issue:3

    Topics: Adult; Analysis of Variance; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Isoxazoles; Japan; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia

2003
Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone.
    Therapeutic drug monitoring, 2003, Volume: 25, Issue:6

    Topics: Adult; Antipsychotic Agents; Drug Monitoring; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone

2003
Transfer of risperidone and 9-hydroxyrisperidone into human milk.
    The Annals of pharmacotherapy, 2004, Volume: 38, Issue:2

    Topics: Adult; Area Under Curve; Breast Feeding; Depression, Postpartum; Female; Galactorrhea; Humans; Infant; Isoxazoles; Male; Milk, Human; Paliperidone Palmitate; Pyrimidines; Risperidone

2004
Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry.
    Journal of chromatography. A, 2004, Feb-13, Volume: 1026, Issue:1-2

    Topics: Adult; Calibration; Chemical Precipitation; Child; Chromatography, Liquid; Humans; Isoxazoles; Mass Spectrometry; Molecular Structure; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Saliva; Sensitivity and Specificity

2004
Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes.
    British journal of clinical pharmacology, 2004, Volume: 57, Issue:5

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Genes, MDR; Genotype; Humans; Isoxazoles; Male; Middle Aged; Mutation; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone; Schizophrenia

2004
QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations.
    Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:2

    Topics: Administration, Oral; Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Electrocardiography; Genotype; Humans; Isoxazoles; Long QT Syndrome; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone

2004
In vitro effects of risperidone and 9-hydroxy-risperidone on human platelet function, plasma coagulation, and fibrinolysis.
    Clinical therapeutics, 2004, Volume: 26, Issue:8

    Topics: Adult; Animals; Aorta; Arachidonic Acid; Blood Coagulation Tests; Clonidine; Epinephrine; Ergotamine; Fibrinolysis; Humans; Isoxazoles; Male; Milrinone; Paliperidone Palmitate; Platelet Aggregation; Pyrimidines; Rats; Rats, Wistar; Reference Values; Risperidone; Serotonin; Serotonin Antagonists; Suprofen

2004
A high-performance liquid chromatographic-atmospheric pressure chemical ionization-tandem mass spectrometric method for determination of risperidone and 9-hydroxyrisperidone in human plasma.
    Journal of analytical toxicology, 2004, Volume: 28, Issue:6

    Topics: Antipsychotic Agents; Calibration; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Indicators and Reagents; Isoxazoles; Mass Spectrometry; Paliperidone Palmitate; Pyrimidines; Quality Control; Reference Standards; Reproducibility of Results; Risperidone

2004
The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein.
    The international journal of neuropsychopharmacology, 2004, Volume: 7, Issue:4

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Chromatography, High Pressure Liquid; Injections, Intraperitoneal; Isoxazoles; Male; Mice; Mice, Transgenic; Paliperidone Palmitate; Pyrimidines; Risperidone; Serotonin Antagonists; Tissue Distribution

2004
Risperidone and breast-feeding.
    Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:2

    Topics: Adult; Antipsychotic Agents; Breast Feeding; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Isoxazoles; Milk, Human; Paliperidone Palmitate; Postpartum Period; Psychotic Disorders; Pyrimidines; Risperidone

2005
Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.
    International clinical psychopharmacology, 2005, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Caffeine; Catecholamines; Central Nervous System Stimulants; Cotinine; Cues; Cytochrome P-450 CYP2D6; Female; Homovanillic Acid; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Smoking

2005
Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels.
    The American journal of psychiatry, 2005, Volume: 162, Issue:5

    Topics: Adolescent; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hyperprolactinemia; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Psychotic Disorders; Pyrimidines; Risperidone

2005
Influence of age and gender on risperidone plasma concentrations.
    Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Sex Characteristics

2005
Subtherapeutic risperidone serum concentrations in an adolescent during hemodialysis: a pharmacological puzzle.
    Therapeutic drug monitoring, 2005, Volume: 27, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Drug Monitoring; Female; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Renal Dialysis; Risperidone; Tics

2005
Plasma risperidone levels and clinical response in patients with first-episode psychosis.
    Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:6

    Topics: Adult; Antipsychotic Agents; Asian People; Drug Monitoring; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Treatment Outcome

2005
Intestinal uptake and biodistribution of novel polymeric micelles after oral administration.
    Journal of controlled release : official journal of the Controlled Release Society, 2006, Mar-10, Volume: 111, Issue:1-2

    Topics: Administration, Oral; Animals; Antipsychotic Agents; Area Under Curve; Biological Availability; Biological Transport; Caco-2 Cells; Carbon Radioisotopes; Enterocytes; Humans; Injections, Intravenous; Intestinal Absorption; Isoxazoles; Kidney; Male; Metabolic Clearance Rate; Micelles; Mononuclear Phagocyte System; Paliperidone Palmitate; Polyesters; Polyethylene Glycols; Polymers; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Tissue Distribution

2006
Multiple dose pharmacokinetics of risperidone and 9-hydroxyrisperidone in Chinese female patients with schizophrenia.
    Acta pharmacologica Sinica, 2006, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Area Under Curve; Asian People; China; Female; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia

2006
A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.
    The American journal of psychiatry, 2006, Volume: 163, Issue:3

    Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Carbon Radioisotopes; Corpus Striatum; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Positron-Emission Tomography; Prolactin; Psychotic Disorders; Pyrimidines; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia

2006
Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation.
    BMC neuroscience, 2006, Mar-30, Volume: 7

    Topics: Animals; Anisoles; Antipsychotic Agents; Benzazepines; Butaclamol; Caspase Inhibitors; Cell Death; Cells, Cultured; Chlorpromazine; Clozapine; Domperidone; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Ginkgo biloba; Haloperidol; Hippocampus; Indans; Isoxazoles; Neurons; Neuroprotective Agents; Peptides; Piperidines; Plant Extracts; Propylamines; Raclopride; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Remoxipride; Risperidone; Sulpiride

2006
Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication.
    Acta psychiatrica Scandinavica, 2006, Volume: 114, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome

2006
Liquid chromatography/tandem mass spectrometry method for simultaneous determination of risperidone and its active metabolite 9-hydroxyrisperidone in human plasma.
    Rapid communications in mass spectrometry : RCM, 2006, Volume: 20, Issue:14

    Topics: Administration, Oral; Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Isoxazoles; Male; Microchemistry; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry

2006
Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats.
    Pharmacology, biochemistry, and behavior, 2006, Volume: 84, Issue:2

    Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Clozapine; Conditioning, Psychological; Dioxoles; Drug Synergism; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Rats, Wistar; Receptors, AMPA; Risperidone; Serine; Stereoisomerism

2006
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
    Psychopharmacology, 2006, Volume: 187, Issue:4

    Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodiazepines; Chlorpromazine; Clozapine; Cyclosporins; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Flow Cytometry; Fluorescent Dyes; Haloperidol; Isoxazoles; Kidney; Liver; LLC-PK1 Cells; Olanzapine; Paliperidone Palmitate; Pyrimidines; Quetiapine Fumarate; Rhodamine 123; Risperidone; Swine; Transfection

2006
Risperidone and paliperidone inhibit p-glycoprotein activity in vitro.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:4

    Topics: Animals; Animals, Newborn; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cerebral Cortex; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Epithelial Cells; Inhibitory Concentration 50; Isoxazoles; Paliperidone Palmitate; Protein Transport; Pyrimidines; Rats; Rhodamine 123; Risperidone; Swine; Time Factors

2007
Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients.
    Pharmacogenomics, 2006, Volume: 7, Issue:7

    Topics: Adult; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; China; Female; Gene Frequency; Humans; Isoxazoles; Linkage Disequilibrium; Male; Organic Anion Transporters; Paliperidone Palmitate; Polymorphism, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology

2006
Prolactin elevation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite.
    Human psychopharmacology, 2006, Volume: 21, Issue:8

    Topics: Adult; Antipsychotic Agents; Biotransformation; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia

2006
Valproic acid improves psychotic agitation without influencing plasma risperidone levels in schizophrenic patients.
    Pharmacopsychiatry, 2007, Volume: 40, Issue:1

    Topics: Adult; Antimanic Agents; Antipsychotic Agents; Drug Interactions; Female; Homovanillic Acid; Humans; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychomotor Agitation; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Valproic Acid

2007
Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MS.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Jun-01, Volume: 852, Issue:1-2

    Topics: Child; Chromatography, Liquid; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Reference Standards; Reproducibility of Results; Risperidone; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Tandem Mass Spectrometry

2007
Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients.
    Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jun-30, Volume: 31, Issue:5

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Catecholamines; Chromatography, High Pressure Liquid; Female; Genotype; Humans; Immunoenzyme Techniques; Isoxazoles; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine Plasma Membrane Transport Proteins; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone; Schizophrenia

2007
Distinct electrophysiological effects of paliperidone and risperidone on the firing activity of rat serotonin and norepinephrine neurons.
    Psychopharmacology, 2007, Volume: 194, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Animals; Antipsychotic Agents; Citalopram; Desipramine; Dose-Response Relationship, Drug; Electrophysiology; Infusion Pumps; Injections, Intravenous; Isoxazoles; Male; Neurons; Norepinephrine; Paliperidone Palmitate; Piperazines; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists

2007
Limitations in discerning the effects of risperidone and its 9-hydroxy metabolite on prolactin levels in a small study of patients with schizophrenia.
    Human psychopharmacology, 2007, Volume: 22, Issue:5

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Paliperidone Palmitate; Prolactin; Pyrimidines; Risperidone; Schizophrenia

2007
Enantioselective analysis of the antipsychotic 9-hydroxyrisperidone, main metabolite of risperidone, by chiral capillary EKC using dual CDs.
    Electrophoresis, 2007, Volume: 28, Issue:15

    Topics: beta-Cyclodextrins; Chromatography, Micellar Electrokinetic Capillary; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Stereoisomerism

2007
Analytical and semipreparative enantioseparation of 9-hydroxyrisperidone, the main metabolite of risperidone, using high-performance liquid chromatography and capillary electrophoresis. Validation and determination of enantiomeric purity.
    Journal of chromatography. A, 2007, Sep-07, Volume: 1163, Issue:1-2

    Topics: Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Isoxazoles; Molecular Structure; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Stereoisomerism

2007
[Development and identifiability analysis of parent-metabolite pharmacokinetic model for risperidone and its main active metabolite 9-hydroxyrisperidone].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2007, Volume: 42, Issue:6

    Topics: Adult; Cytochrome P-450 CYP2D6; Humans; Isoxazoles; Male; Models, Biological; Monte Carlo Method; Paliperidone Palmitate; Pyrimidines; Risperidone

2007
Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia.
    Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:8

    Topics: Adolescent; Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Prolactin; Pyrimidines; Risperidone; Schizophrenia

2007
Sensitive liquid chromatography/tandem mass spectrometry method for the simultaneous determination of olanzapine, risperidone, 9-hydroxyrisperidone, clozapine, haloperidol and ziprasidone in rat brain tissue.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Oct-15, Volume: 858, Issue:1-2

    Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Chromatography, Liquid; Clozapine; Haloperidol; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Rats; Reproducibility of Results; Risperidone; Tandem Mass Spectrometry; Thiazoles

2007
Identification, isolation and characterization of potential degradation product in risperidone tablets.
    Journal of pharmaceutical and biomedical analysis, 2008, Jan-07, Volume: 46, Issue:1

    Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Contamination; Drug Stability; Hot Temperature; Isoxazoles; Light; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Chemical; Molecular Structure; Risperidone; Tablets

2008
Relationship between prolactin secretion, and plasma risperidone and 9-hydroxyrisperidone concentrations in adolescents with schizophreniform disorder.
    Psychoneuroendocrinology, 2008, Volume: 33, Issue:2

    Topics: Adolescent; Adolescent Medicine; Age Factors; Antipsychotic Agents; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Isoxazoles; Male; Paliperidone Palmitate; Prolactin; Psychotic Disorders; Pyrimidines; Risperidone

2008
Paliperidone: new drug. Just a metabolite of risperidone, a neuroleptic soon off-patent.
    Prescrire international, 2007, Volume: 16, Issue:92

    Topics: Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Isoxazoles; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome

2007
Pharmacodynamic consequences of P-glycoprotein-dependent pharmacokinetics of risperidone and haloperidol in mice.
    Behavioural brain research, 2008, Apr-09, Volume: 188, Issue:2

    Topics: Animals; Antipsychotic Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Mice; Mice, Knockout; Motor Activity; Paliperidone Palmitate; Pyrimidines; Risperidone; Time Factors

2008
Paliperidone: An improvement over risperidone?
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, Mar-01, Volume: 65, Issue:5

    Topics: Administration, Oral; Antipsychotic Agents; Delayed-Action Preparations; Humans; Isoxazoles; Marketing; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia

2008
Validated LC-MS/MS methods for the determination of risperidone and the enantiomers of 9-hydroxyrisperidone in human plasma and urine.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008, Jul-01, Volume: 870, Issue:1

    Topics: Chromatography, Liquid; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Sensitivity and Specificity; Tandem Mass Spectrometry

2008
Long-term therapeutic drug monitoring of risperidone and olanzapine identifies altered steady-state pharmacokinetics: a clinical, two-group, naturalistic study.
    Clinical drug investigation, 2008, Volume: 28, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antipsychotic Agents; Benzodiazepines; Biotransformation; Cytochrome P-450 CYP2D6; Drug Monitoring; Female; Humans; Inpatients; Isoxazoles; Male; Mental Disorders; Middle Aged; Olanzapine; Paliperidone Palmitate; Pyrimidines; Regression Analysis; Risperidone; Schizophrenia; Young Adult

2008
ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:5

    Topics: Adult; Alleles; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Genetic Variation; Genotype; Haplotypes; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone

2008
Impact of multiple inhibitors or substrates of cytochrome P450 2D6 on plasma risperidone levels in patients on polypharmacy.
    Therapeutic drug monitoring, 2008, Volume: 30, Issue:5

    Topics: Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polypharmacy; Pyrimidines; Risperidone; Substrate Specificity

2008
Effects of quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human neuronal and immune cells in vitro.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:3

    Topics: Adenosine Triphosphate; Antipsychotic Agents; Cell Line; Cell Survival; Dibenzothiazepines; Dose-Response Relationship, Drug; Energy Metabolism; Humans; Isoxazoles; Monocytes; Neurons; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Risperidone; Thiazoles

2010
[Paliperidone--a novel second-generation antipsychotic].
    Ugeskrift for laeger, 2008, Aug-25, Volume: 170, Issue:35

    Topics: Antipsychotic Agents; Delayed-Action Preparations; Evidence-Based Medicine; Half-Life; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Treatment Outcome

2008
Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study.
    British journal of clinical pharmacology, 2008, Volume: 66, Issue:5

    Topics: Adult; Age Factors; Aged; Alzheimer Disease; Antipsychotic Agents; Biological Availability; Body Weight; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Models, Chemical; Models, Statistical; Paliperidone Palmitate; Pyrimidines; Randomized Controlled Trials as Topic; Risperidone; Sample Size; Sampling Studies; Schizophrenia

2008
Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists.
    Molecular pharmacology, 2009, Volume: 75, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cell Line; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Receptors, Serotonin; Risperidone; Serotonin Antagonists

2009
Study of the complexation of risperidone and 9-hydroxyrisperidone with cyclodextrin hosts using affinity capillary electrophoresis and (1)H NMR spectroscopy.
    Journal of chromatography. A, 2008, Dec-26, Volume: 1215, Issue:1-2

    Topics: Antipsychotic Agents; Cyclodextrins; Electrophoresis, Capillary; Isoxazoles; Magnetic Resonance Spectroscopy; Molecular Structure; Paliperidone Palmitate; Pyrimidines; Risperidone; Thermodynamics

2008
An agonist-antagonist interaction model for prolactin release following risperidone and paliperidone treatment.
    Clinical pharmacology and therapeutics, 2009, Volume: 85, Issue:4

    Topics: Drug Interactions; Female; Humans; Isoxazoles; Male; Models, Biological; Paliperidone Palmitate; Prolactin; Pyrimidines; Risperidone

2009
Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2009, Volume: 17, Issue:3

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Case-Control Studies; Cross-Sectional Studies; Dopamine Antagonists; Female; Humans; Isoxazoles; Male; Middle Aged; Ontario; Paliperidone Palmitate; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Raclopride; Receptors, Dopamine D2; Risperidone; Schizophrenia; Treatment Outcome

2009
Determination of risperidone and 9-Hydroxyrisperidone using HPLC, in plasma of children and adolescents with emotional and behavioural disorders.
    Biomedical chromatography : BMC, 2009, Volume: 23, Issue:9

    Topics: Adolescent; Antipsychotic Agents; Child; Chromatography, High Pressure Liquid; Female; Humans; Isoxazoles; Linear Models; Male; Mental Disorders; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Sensitivity and Specificity

2009
Effects of the CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia.
    Human psychopharmacology, 2009, Volume: 24, Issue:4

    Topics: Adult; Alleles; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Drug Therapy, Combination; Female; Genotype; Humans; Isoxazoles; Male; Oligonucleotide Array Sequence Analysis; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Regression Analysis; Risperidone; Schizophrenia

2009
Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:7

    Topics: Adolescent; Adult; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; DNA; Dose-Response Relationship, Drug; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult

2010
Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients.
    Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:3

    Topics: Adult; Antipsychotic Agents; Asian People; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Genotype; Humans; Isoxazoles; Korea; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Risperidone; Schizophrenia

2009
Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders.
    Psychiatry and clinical neurosciences, 2009, Volume: 63, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Asian People; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Treatment Outcome; White People

2009
Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients.
    Journal of psychopharmacology (Oxford, England), 2010, Volume: 24, Issue:7

    Topics: Adult; Aged; Antipsychotic Agents; Anxiety; Cognition; Data Interpretation, Statistical; Depression; Female; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult

2010
Human 5-HT7 receptor-induced inactivation of forskolin-stimulated adenylate cyclase by risperidone, 9-OH-risperidone and other "inactivating antagonists".
    Molecular pharmacology, 2009, Volume: 76, Issue:3

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Cell Line; Colforsin; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Receptors, Serotonin; Risperidone; Serotonin Antagonists

2009
Serum levels of risperidone and its metabolite, 9-hydroxyrisperidone: correlation between drug concentration and clinical response.
    Therapeutic drug monitoring, 2009, Volume: 31, Issue:4

    Topics: Adult; Antipsychotic Agents; Attention; Blood Chemical Analysis; Discrimination Learning; Drug Monitoring; Female; Humans; Hydroxylation; Isoxazoles; Liver; Male; Neuropsychological Tests; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Schizophrenic Psychology

2009
Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detection.
    Journal of pharmaceutical and biomedical analysis, 2009, Dec-05, Volume: 50, Issue:5

    Topics: Antipsychotic Agents; Buffers; Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Chromatography, Liquid; Electrochemistry; Humans; Isoxazoles; Methanol; Paliperidone Palmitate; Phosphates; Pyrimidines; Reproducibility of Results; Risperidone; Stereoisomerism; Time Factors

2009
Time resolved analysis of risperidone and 9-hydroxy-risperidone in hair using LC/MS-MS.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009, Aug-15, Volume: 877, Issue:24

    Topics: Adult; Antipsychotic Agents; Chromatography, Liquid; Hair; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Tandem Mass Spectrometry; Time Factors

2009
A comparison of continuous subcutaneous paliperidone infusion and repeated subcutaneous injection of risperidone free-base in rats.
    European psychiatry : the journal of the Association of European Psychiatrists, 2010, Volume: 25, Issue:2

    Topics: Animals; Antipsychotic Agents; Dextroamphetamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Administration Schedule; Infusions, Subcutaneous; Injections, Subcutaneous; Isoxazoles; Locomotion; Male; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone

2010
Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission?
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Oct-28, Volume: 29, Issue:43

    Topics: Adult; Antipsychotic Agents; Brain; Carbon Radioisotopes; Caudate Nucleus; Dopamine; Dose-Response Relationship, Drug; Humans; Isoxazoles; Levodopa; Male; Paliperidone Palmitate; Positron-Emission Tomography; Putamen; Pyrimidines; Raclopride; Receptors, Dopamine D2; Rest; Risperidone; Synaptic Transmission; Young Adult

2009
Impact of CYP2D6 genotype on steady-state serum concentrations of risperidone and 9-hydroxyrisperidone in patients using long-acting injectable risperidone.
    Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:6

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Female; Genotype; Humans; Injections, Intramuscular; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Retrospective Studies; Risperidone; Time Factors; Young Adult

2009
Inconsistency in risperidone long-acting injection steady-state plasma levels when switching from deltoid to gluteal administration.
    Journal of clinical pharmacology, 2010, Volume: 50, Issue:6

    Topics: Adult; Antipsychotic Agents; Buttocks; Delayed-Action Preparations; Humans; Injections, Intramuscular; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Shoulder

2010
Remission of drug-induced hepatitis after switching from risperidone to paliperidone.
    The American journal of psychiatry, 2010, Volume: 167, Issue:3

    Topics: Adult; Antipsychotic Agents; Biotransformation; Chemical and Drug Induced Liver Injury; Clozapine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Isoxazoles; Liver Function Tests; Paliperidone Palmitate; Pyrimidines; Reference Values; Risperidone; Schizophrenia

2010
Serum concentrations, therapeutic response and side effects in children and adolescents with impulsive-aggressive symptoms during risperidone therapy.
    Pharmacopsychiatry, 2010, Volume: 43, Issue:2

    Topics: Adolescent; Age Factors; Aggression; Antipsychotic Agents; Child; Child Behavior Disorders; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Female; Humans; Isoxazoles; Linear Models; Male; Paliperidone Palmitate; Prospective Studies; Psychiatric Status Rating Scales; Pyrimidines; Risperidone; Sex Factors; Treatment Outcome

2010
Serum concentrations of paliperidone versus risperidone and clinical effects.
    European journal of clinical pharmacology, 2010, Volume: 66, Issue:8

    Topics: Adult; Antipsychotic Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Monitoring; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Psychiatric Status Rating Scales; Pyrimidines; Retrospective Studies; Risperidone

2010
The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone.
    European journal of clinical pharmacology, 2010, Volume: 66, Issue:11

    Topics: Adult; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Mutation; Paliperidone Palmitate; Pyrimidines; Risperidone; Sample Size; Schizophrenia; Treatment Outcome

2010
Studies on the acute toxicity, pharmacokinetics and pharmacodynamics of paliperidone derivatives--comparison to paliperidone and risperidone in mice and rats.
    Basic & clinical pharmacology & toxicology, 2010, Volume: 107, Issue:2

    Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Electrocardiography; Excitatory Amino Acid Antagonists; Female; Heart; Heart Rate; Hyperkinesis; Isoxazoles; Lethal Dose 50; Male; Maximum Tolerated Dose; Mice; Mice, Inbred Strains; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Toxicity Tests, Acute

2010
Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats.
    Brain research, 2010, Oct-01, Volume: 1354

    Topics: Analysis of Variance; Animals; Antipsychotic Agents; Cell Count; Cell Proliferation; Dose-Response Relationship, Drug; Fluoxetine; Hippocampus; Isoxazoles; Lateral Ventricles; Male; Neurogenesis; Neurons; Olfactory Mucosa; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Selective Serotonin Reuptake Inhibitors

2010
Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT7 receptors: radioligand binding and functional evidence for GPCR homodimer protomer interactions.
    Psychopharmacology, 2010, Volume: 212, Issue:4

    Topics: Binding, Competitive; Biosensing Techniques; Cell Line; Clozapine; Cyclic AMP; Dose-Response Relationship, Drug; Humans; Isoxazoles; Paliperidone Palmitate; Protein Binding; Protein Multimerization; Protein Subunits; Pyrimidines; Radioligand Assay; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Transfection

2010
Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases.
    Current drug safety, 2011, Feb-01, Volume: 6, Issue:1

    Topics: Chemistry, Pharmaceutical; Clinical Trials as Topic; Conscious Sedation; Databases, Factual; Delayed-Action Preparations; Delirium; Humans; Injections, Intramuscular; Isoxazoles; Paliperidone Palmitate; Palmitates; Prospective Studies; Risperidone; Syndrome

2011
Effect of cyamemazine on the steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: a preliminary retrospective study.
    Therapeutic drug monitoring, 2010, Volume: 32, Issue:6

    Topics: Adolescent; Adult; Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Phenothiazines; Pyrimidines; Retrospective Studies; Risperidone; Spectrophotometry, Ultraviolet

2010
Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Jan-15, Volume: 879, Issue:2

    Topics: Chromatography, Liquid; Humans; Isoxazoles; Linear Models; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Reproducibility of Results; Risperidone; Saliva; Sensitivity and Specificity; Solid Phase Microextraction; Spectrophotometry, Ultraviolet

2011
Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis.
    BMC psychiatry, 2011, Feb-07, Volume: 11

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Databases as Topic; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Isoxazoles; Male; Paliperidone Palmitate; Propensity Score; Psychiatric Status Rating Scales; Pyrimidines; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Treatment Outcome

2011
The interaction of antipsychotic drugs with lipids and subsequent lipid reorganization investigated using biophysical methods.
    Biochimica et biophysica acta, 2011, Volume: 1808, Issue:8

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Antipsychotic Agents; Calorimetry, Differential Scanning; Cell Membrane; Cholesterol; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Isoxazoles; Membrane Lipids; Membranes, Artificial; Microscopy, Fluorescence; Models, Molecular; Molecular Conformation; Molecular Structure; Paliperidone Palmitate; Phosphatidylcholines; Pyrimidines; Receptors, Dopamine D2; Risperidone; Sphingomyelins; Structure-Activity Relationship; Surface Plasmon Resonance; X-Ray Diffraction

2011
Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation.
    Journal of psychiatric research, 2011, Volume: 45, Issue:9

    Topics: Amphetamine; Animals; Animals, Newborn; Antipsychotic Agents; Central Nervous System Stimulants; Disease Models, Animal; Drug Interactions; Female; Isoxazoles; Motor Activity; Paliperidone Palmitate; Poly I-C; Pregnancy; Prenatal Exposure Delayed Effects; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Time Factors

2011
Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression.
    Schizophrenia research, 2011, Volume: 129, Issue:1

    Topics: Animals; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drinking Water; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Haloperidol; Isoxazoles; Linoleoyl-CoA Desaturase; Liver; Male; Olanzapine; Paliperidone Palmitate; Pyrimidines; Quetiapine Fumarate; Rats; Rats, Long-Evans; Risperidone; RNA, Messenger

2011
Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents.
    Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:2

    Topics: Adolescent; Aging; Antipsychotic Agents; Body Mass Index; Child; Child Development Disorders, Pervasive; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Mental Disorders; Paliperidone Palmitate; Polypharmacy; Psychotic Disorders; Pyrimidines; Risperidone; Sex Factors; Sexual Development

2011
Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
    The Journal of clinical psychiatry, 2011, Volume: 72, Issue:4

    Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Crime; Delayed-Action Preparations; Dibenzothiazepines; Female; Florida; Humans; Isoxazoles; Male; Medicaid; Middle Aged; Olanzapine; Outpatients; Paliperidone Palmitate; Piperazines; Propensity Score; Pyrimidines; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Schizophrenia; Treatment Outcome; United States; Young Adult

2011
MultiSimplex optimization of chromatographic separation and dansyl derivatization conditions in the ultra performance liquid chromatography-tandem mass spectrometry analysis of risperidone, 9-hydroxyrisperidone, monoamine and amino acid neurotransmitters
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Jul-01, Volume: 879, Issue:21

    Topics: Biogenic Monoamines; Case-Control Studies; Chromatography, High Pressure Liquid; Dansyl Compounds; Humans; Isoxazoles; Multivariate Analysis; Neurotransmitter Agents; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Schizophrenia; Sensitivity and Specificity; Tandem Mass Spectrometry

2011
Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801.
    Neuroscience letters, 2011, Aug-18, Volume: 500, Issue:3

    Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Extracellular Space; Female; Glutamic Acid; Isoxazoles; Male; Maternal Exposure; Paliperidone Palmitate; Poly I-C; Prefrontal Cortex; Pregnancy; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Risperidone; Schizophrenia

2011
Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone.
    Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:5

    Topics: Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Monitoring; Female; Genotype; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Young Adult

2011
Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells.
    Progress in neuro-psychopharmacology & biological psychiatry, 2012, Jan-10, Volume: 36, Issue:1

    Topics: Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Humans; Isoxazoles; Neuroblastoma; Neuroprotective Agents; Paliperidone Palmitate; Pyrimidines; Risperidone

2012
Enantioselective fungal biotransformation of risperidone in liquid culture medium by capillary electrophoresis and hollow fiber liquid-phase microextraction.
    Electrophoresis, 2011, Volume: 32, Issue:19

    Topics: Analysis of Variance; Biotransformation; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Isoxazoles; Linear Models; Liquid Phase Microextraction; Mucor; Paliperidone Palmitate; Pilot Projects; Pyrimidines; Reproducibility of Results; Risperidone; Sensitivity and Specificity; Stereoisomerism

2011
Manic symptoms during a switch from risperidone to paliperidone: a case report.
    The Journal of neuropsychiatry and clinical neurosciences, 2011,Summer, Volume: 23, Issue:3

    Topics: Antipsychotic Agents; Bipolar Disorder; Female; Follow-Up Studies; Humans; Isoxazoles; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia

2011
Anaphylactoid reaction to paliperidone palmitate extended-release injectable suspension in a patient tolerant of oral risperidone.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2012, Jan-01, Volume: 69, Issue:1

    Topics: Administration, Oral; Adult; Anaphylaxis; Antipsychotic Agents; Delayed-Action Preparations; Humans; Injections, Intramuscular; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia; Suspensions

2012
[Case of schizophrenia in which depressive and negative symptoms relapsed on switching from oral risperidone to risperidone long-acting injection].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2011, Volume: 113, Issue:10

    Topics: Administration, Ophthalmic; Antipsychotic Agents; Delayed-Action Preparations; Drug Substitution; Humans; Injections; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Receptors, Adrenergic, alpha-2; Recurrence; Risperidone; Schizophrenia; Schizophrenic Psychology

2011
Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:1

    Topics: Animals; Antipsychotic Agents; Brain; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Isoxazoles; Macaca mulatta; Male; Paliperidone Palmitate; Positron-Emission Tomography; Protein Binding; Pyrimidines; Receptors, Dopamine D2; Risperidone

2012
Emergence of neuroleptic malignant syndrome while switching between risperidone and paliperidone.
    The Journal of neuropsychiatry and clinical neurosciences, 2011,Fall, Volume: 23, Issue:4

    Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone

2011
A change from risperidone long acting injection to paliperidone palmitate in an elderly patient--a cautionary tale.
    The Australian and New Zealand journal of psychiatry, 2012, Volume: 46, Issue:2

    Topics: Aged; Antipsychotic Agents; Female; Humans; Isoxazoles; Paliperidone Palmitate; Palmitates; Recurrence; Risperidone; Schizophrenia; Treatment Failure

2012
Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats.
    Pharmaceutical research, 2012, Volume: 29, Issue:7

    Topics: Animals; Antipsychotic Agents; Brain; Isoxazoles; Male; Models, Biological; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone

2012
Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database.
    PLoS medicine, 2012, Volume: 9, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Databases, Factual; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Publication Bias; Pyrimidines; Quetiapine Fumarate; Quinolones; Risperidone; United States; United States Food and Drug Administration

2012
Cost effectiveness of paliperidone palmitate versus risperidone long-acting injectable and olanzapine pamoate for the treatment of patients with schizophrenia in Sweden.
    Journal of medical economics, 2012, Volume: 15, Issue:5

    Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Drug Substitution; Female; Health Resources; Humans; Injections; Isoxazoles; Male; Markov Chains; Models, Economic; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Recurrence; Risperidone; Schizophrenia; Sweden

2012
Risperidone and total 9-hydroxyrisperidone in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2002-2010.
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Databases, Factual; Drug Monitoring; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Pyrimidines; Risperidone; Treatment Outcome; Young Adult

2012
Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein.
    Progress in neuro-psychopharmacology & biological psychiatry, 2012, Oct-01, Volume: 39, Issue:1

    Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Brain; Cell Line, Transformed; Humans; Isoxazoles; LLC-PK1 Cells; Mice; Mice, Inbred Strains; Mice, Knockout; Paliperidone Palmitate; Piperazines; Piperidines; Pyrimidines; Risperidone; Swine

2012
Effect of the cytochrome P450 2D6*10 allele on risperidone metabolism in Japanese psychiatric patients.
    Human psychopharmacology, 2012, Volume: 27, Issue:1

    Topics: Adult; Alleles; Antipsychotic Agents; Cytochrome P-450 CYP2D6; Female; Humans; Isoxazoles; Japan; Male; Middle Aged; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone; Schizophrenia; Young Adult

2012
Solid phase microextraction and LC-MS/MS for the determination of paliperidone after stereoselective fungal biotransformation of risperidone.
    Analytica chimica acta, 2012, Sep-12, Volume: 742

    Topics: Biotransformation; Chromatography, Liquid; Culture Media; Cunninghamella; Isoxazoles; Molecular Structure; Paliperidone Palmitate; Pyrimidines; Risperidone; Solid Phase Microextraction; Solvents; Stereoisomerism; Tandem Mass Spectrometry

2012
An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:11

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Brain Chemistry; Dogs; Isoxazoles; Male; Paliperidone Palmitate; Primates; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Thiophenes

2012
Population pharmacokinetic modeling of risperidone and 9-hydroxyrisperidone to estimate CYP2D6 subpopulations in children and adolescents.
    Therapeutic drug monitoring, 2012, Volume: 34, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Child; Child, Preschool; Cohort Studies; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Isoxazoles; Male; Mental Disorders; Paliperidone Palmitate; Phenotype; Prospective Studies; Pyrimidines; Risperidone

2012
A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:8

    Topics: Adult; Aged; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gas Chromatography-Mass Spectrometry; Humans; Injections, Intramuscular; Isoxazoles; Long-Term Care; Male; Middle Aged; Paliperidone Palmitate; Positron-Emission Tomography; Psychiatric Status Rating Scales; Pyrimidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Young Adult

2012
Risperidone/paliperidone induced neutropenia and lymphopenia.
    The Australian and New Zealand journal of psychiatry, 2013, Volume: 47, Issue:3

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Lymphopenia; Male; Middle Aged; Neutropenia; Paliperidone Palmitate; Pyrimidines; Risperidone

2013
Bacterial degradation of risperidone and paliperidone in decomposing blood.
    Journal of forensic sciences, 2013, Volume: 58, Issue:1

    Topics: Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Stability; Forensic Toxicology; Gram-Positive Bacteria; Isoxazoles; Paliperidone Palmitate; Postmortem Changes; Pyrimidines; Risperidone; Specimen Handling; Spectrometry, Mass, Electrospray Ionization; Swine; Temperature

2013
Paliperidone as an alternative for risperidone in a case of schizophrenia with retrograde ejaculation.
    The Journal of neuropsychiatry and clinical neurosciences, 2012,Summer, Volume: 24, Issue:3

    Topics: Adult; Antipsychotic Agents; Ejaculation; Humans; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Sexual Dysfunction, Physiological

2012
Effects of single or repeated silymarin administration on pharmacokinetics of risperidone and its major metabolite, 9-hydroxyrisperidone in rats.
    Xenobiotica; the fate of foreign compounds in biological systems, 2013, Volume: 43, Issue:3

    Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Injections, Intravenous; Isoxazoles; Male; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Silymarin

2013
Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate.
    International clinical psychopharmacology, 2013, Volume: 28, Issue:1

    Topics: Adult; Age Factors; Antipsychotic Agents; Biomarkers; Drug Substitution; Female; Humans; Hyperprolactinemia; Injections; Isoxazoles; Male; Paliperidone Palmitate; Palmitates; Prolactin; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Recovery of Function; Risperidone; Sexual Behavior; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult

2013
Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.
    Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:6

    Topics: Adolescent; Adult; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Child; Child Development Disorders, Pervasive; Cross-Sectional Studies; Dose-Response Relationship, Drug; Gynecomastia; Humans; Hyperprolactinemia; Isoxazoles; Logistic Models; Male; Paliperidone Palmitate; Prolactin; Pyrimidines; Risperidone; Sexual Dysfunction, Physiological; Statistics, Nonparametric; Surveys and Questionnaires; Time Factors; Young Adult

2012
Treating residual insomnia in schizophrenia: examining the options.
    Acta psychiatrica Scandinavica, 2013, Volume: 127, Issue:1

    Topics: Antipsychotic Agents; Central Nervous System Depressants; Humans; Isoxazoles; Melatonin; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia; Sleep Initiation and Maintenance Disorders

2013
LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood.
    Forensic science international, 2013, Jun-10, Volume: 229, Issue:1-3

    Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry

2013
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia.
    Journal of psychosocial nursing and mental health services, 2013, Volume: 51, Issue:3

    Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia

2013
Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum.
    Forensic science international, 2013, Jun-10, Volume: 229, Issue:1-3

    Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cattle; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Drug Stability; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry

2013
Impact of the ABCB1 gene polymorphism on plasma 9-hydroxyrisperidone and active moiety levels in Japanese patients with schizophrenia.
    Journal of clinical psychopharmacology, 2013, Volume: 33, Issue:3

    Topics: Adult; Age Factors; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Isoxazoles; Japan; Male; Middle Aged; Paliperidone Palmitate; Polymorphism, Genetic; Pyrimidines; Regression Analysis; Risperidone; Schizophrenia; Young Adult

2013
Economic and clinical comparison of atypical depot antipsychotic drugs for treatment of chronic schizophrenia in the Czech Republic.
    Journal of medical economics, 2013, Volume: 16, Issue:9

    Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Czech Republic; Decision Support Techniques; Delayed-Action Preparations; Drug Costs; Economics, Pharmaceutical; Female; Humans; Isoxazoles; Male; Multivariate Analysis; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Young Adult

2013
Signalling profile differences: paliperidone versus risperidone.
    British journal of pharmacology, 2013, Volume: 170, Issue:3

    Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Arrestins; beta-Arrestins; CHO Cells; Cricetinae; Cricetulus; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Inverse Agonism; Extracellular Signal-Regulated MAP Kinases; Histamine Agonists; Humans; Isoxazoles; Molecular Structure; Paliperidone Palmitate; Pyrimidines; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Receptors, Histamine H1; Risperidone; Serotonin Receptor Agonists; Signal Transduction; Structure-Activity Relationship; Transfection

2013
Cost-effectiveness analysis of atypical long-acting antipsychotics for treating chronic schizophrenia in Finland.
    Journal of medical economics, 2013, Volume: 16, Issue:9

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Cost-Benefit Analysis; Decision Support Techniques; Delayed-Action Preparations; Drug Costs; Economics, Pharmaceutical; Female; Finland; Humans; Isoxazoles; Male; Multivariate Analysis; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Young Adult

2013
The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.
    Pharmacogenetics and genomics, 2013, Volume: 23, Issue:9

    Topics: Adolescent; Alleles; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Child; Child Development Disorders, Pervasive; Cytochrome P-450 CYP2D6; Drug Administration Schedule; Genetic Variation; Humans; Hyperprolactinemia; Isoxazoles; Male; Paliperidone Palmitate; Polymorphism, Genetic; Prolactin; Pyrimidines; Receptors, Dopamine D2; Risperidone; Young Adult

2013
Microsphere delivery of Risperidone as an alternative to combination therapy.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2013, Volume: 85, Issue:3 Pt A

    Topics: Animals; Antipsychotic Agents; Area Under Curve; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Isoxazoles; Lactic Acid; Male; Microspheres; Paliperidone Palmitate; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Pyrimidines; Rats; Rats, Sprague-Dawley; Risperidone; Time Factors

2013
Johnson & Johnson to pay $2.2bn to settle charges of false marketing on three drugs.
    BMJ (Clinical research ed.), 2013, Nov-06, Volume: 347

    Topics: Consumer Product Safety; Drug Industry; Fraud; Humans; Isoxazoles; Marketing; Natriuretic Peptide, Brain; Paliperidone Palmitate; Pyrimidines; Risperidone; United States; United States Food and Drug Administration

2013
Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden.
    Nordic journal of psychiatry, 2014, Volume: 68, Issue:6

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost of Illness; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Female; Haloperidol; Health Care Costs; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Models, Econometric; Olanzapine; Paliperidone Palmitate; Palmitates; Quality-Adjusted Life Years; Risperidone; Schizophrenia; Sweden

2014
Atypical antipsychotics such as risperidone, but not paliperidone, worsen vascular endothelial function via upregulation of adhesion molecules VCAM-1, ICAM-1, and E-selectin in diabetic rats.
    Canadian journal of physiology and pharmacology, 2013, Volume: 91, Issue:12

    Topics: Animals; Antipsychotic Agents; Aorta; Blood Pressure; Cell Adhesion Molecules; Chemokine CCL2; Cytokines; Diabetes Mellitus, Experimental; Diet, High-Fat; E-Selectin; Endothelium, Vascular; Glucose; Insulin Resistance; Isoxazoles; Lipids; Male; Paliperidone Palmitate; Pyrimidines; Rats; Rats, Wistar; Risperidone; Tumor Necrosis Factor-alpha; Up-Regulation; Vascular Cell Adhesion Molecule-1

2013
Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient.
    The Journal of neuropsychiatry and clinical neurosciences, 2014, Apr-01, Volume: 26, Issue:2

    Topics: Adult; Antipsychotic Agents; Appetite; Body Weight; Female; Humans; Isoxazoles; Paliperidone Palmitate; Psychotic Disorders; Pyrimidines; Risperidone

2014
Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach.
    Pharmaceutical research, 2014, Volume: 31, Issue:10

    Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Catalepsy; Computer Simulation; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Isoxazoles; Markov Chains; Models, Biological; Olanzapine; Paliperidone Palmitate; Pyrimidines; Rats; Receptors, Dopamine D2; Risperidone; Severity of Illness Index

2014
Relationship between the plasma concentration of paliperidone and the clinical and drug-induced extrapyramidal symptoms in elderly patients with schizophrenia.
    Human psychopharmacology, 2014, Volume: 29, Issue:3

    Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Blood Chemical Analysis; Chromatography, Liquid; Female; Humans; Isoxazoles; Male; Middle Aged; Paliperidone Palmitate; Prospective Studies; Pyrimidines; Risperidone; Schizophrenia; Severity of Illness Index; Tandem Mass Spectrometry; Treatment Outcome

2014
Expanding Therapy With Long-Acting Antipsychotic Medication in Patients With Schizophrenia.
    JAMA psychiatry, 2015, Volume: 72, Issue:8

    Topics: Early Medical Intervention; Female; Humans; Isoxazoles; Male; Palmitates; Risperidone; Schizophrenia; Secondary Prevention

2015
ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety.
    Naunyn-Schmiedeberg's archives of pharmacology, 2016, Volume: 389, Issue:6

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Aripiprazole; Behavior, Animal; Benzodiazepines; Conditioning, Psychological; Conflict, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Isoxazoles; Male; Maze Learning; Mice; Motor Activity; Olanzapine; Punishment; Rats, Wistar; Reaction Time; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Sulfonamides

2016
[Therapeutic drug monitoring of risperidone and its active metabolite 9-hydroxyrisperidone in the treatment of schizophrenia].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2019, Volume: 119, Issue:3

    Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Risperidone; Schizophrenia

2019
Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone.
    BMC psychiatry, 2021, 02-03, Volume: 21, Issue:1

    Topics: Antipsychotic Agents; Cytochrome P-450 CYP2D6; Humans; Isoxazoles; Paliperidone Palmitate; Plasma; Pyrimidines; Risperidone

2021
A liquid chromatography-miniature mass spectrometry (LC-Mini MS) method for quantitative analysis of risperidone and 9-hydroxyrisperidone in plasma.
    The Analyst, 2023, Jul-26, Volume: 148, Issue:15

    Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Isoxazoles; Paliperidone Palmitate; Pyrimidines; Reproducibility of Results; Risperidone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry

2023